Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transferrin receptor activity	TFR2 TFRC	7.81e-05	2	177	2	GO:0004998
GeneOntologyMolecularFunction	transcription coregulator activity	NCOA2 TOB2 SUPT20H NACA PEX14 SUPT20HL2 EWSR1 MED1 NCOR2 ARID1B KMT2D TLE3 YY1AP1 MAML2 SPEN	1.51e-04	562	177	15	GO:0003712
GeneOntologyMolecularFunction	molecular adaptor activity	NCOA2 TOB2 MAP2K4 PAG1 SUPT20H NELFA NACA PEX14 TAB2 SUPT20HL2 EWSR1 MED1 WNK1 NCOR2 ARID1B KMT2D MAVS TLE3 TJP2 YY1AP1 MICAL3 MAML2 ZNF598 SPEN FKBP4 WNK3	1.61e-04	1356	177	26	GO:0060090
GeneOntologyBiologicalProcess	import into cell	DOCK1 FKBP15 HSPG2 PDLIM7 RPS6KB1 SLC38A5 TSC2 DENND1C ARHGEF11 GRM6 WNK1 GDNF TFR2 TFRC FCGR2C EPS15L1 FCGR2B ATXN2 KCNQ2 ROCK1 CACNA1G NEURL1B MYO15A RUBCN XKR5 WNK3	1.50e-06	1074	176	26	GO:0098657
GeneOntologyBiologicalProcess	antigen receptor-mediated signaling pathway	RC3H1 LCP2 WNK1 PRAM1 IGLC7 CD19 FCGR2B NECTIN2 IGLC1 IGLC3 IGLC6	3.54e-06	223	176	11	GO:0050851
GeneOntologyBiologicalProcess	immunoglobulin mediated immune response	PARP3 TFRC FCGR2C IGLC7 CD19 FCGR2B NECTIN2 IGLC1 IGLC2 IGLC3 IGLC6	5.84e-06	235	176	11	GO:0016064
GeneOntologyBiologicalProcess	immune response-regulating cell surface receptor signaling pathway	MAP2K4 RC3H1 LCP2 WNK1 OPRPN PRAM1 FCGR2C IGLC7 CD19 FCGR2B NECTIN2 IGLC1 IGLC3 IGLC6	7.45e-06	393	176	14	GO:0002768
GeneOntologyBiologicalProcess	B cell mediated immunity	PARP3 TFRC FCGR2C IGLC7 CD19 FCGR2B NECTIN2 IGLC1 IGLC2 IGLC3 IGLC6	8.34e-06	244	176	11	GO:0019724
GeneOntologyBiologicalProcess	postsynapse organization	DOCK1 LRFN1 PRICKLE1 CC2D1A TSC2 GDNF ARHGEF15 NRP1 NEDD9 DACT1 FCGR2B FARP1	1.65e-05	313	176	12	GO:0099173
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	NCOA2 ZNF142 ZNF219 SUPT20H CEBPD NELFA SOX30 NACA SUPT20HL2 TSC2 MED1 KDM6B GDNF TFR2 EBF2 OSM KMT2D KLF10 MAVS ZFHX3 MAML2 NKX3-1 CREB3L3 TNFRSF1A MGA ST18 PYGO1 PROX1	1.87e-05	1390	176	28	GO:0045944
GeneOntologyBiologicalProcess	immune response-regulating signaling pathway	MAP2K4 LILRB3 RC3H1 LILRA6 LCP2 WNK1 OPRPN PRAM1 FCGR2C MAVS IGLC7 CD19 FCGR2B NECTIN2 IGLC1 IGLC3 IGLC6	2.18e-05	615	176	17	GO:0002764
GeneOntologyBiologicalProcess	synapse organization	DOCK1 LRFN1 CTTNBP2 PRICKLE1 PCLO CC2D1A TSC2 GRM6 GDNF ARHGEF15 NRP1 NEDD9 OPRPN DACT1 FCGR2B FARP1 ROCK1 KIF5B	2.42e-05	685	176	18	GO:0050808
GeneOntologyBiologicalProcess	heart development	HSPG2 MAP2K4 FAT4 PRICKLE1 PDLIM7 SPEG NACA TAB2 TSC2 MED1 KDM6B WNK1 NRP1 NCOR2 ROCK1 CACNA1G NKX3-1 TNFRSF1A PROX1	2.67e-05	757	176	19	GO:0007507
GeneOntologyBiologicalProcess	regulation of synapse organization	DOCK1 LRFN1 CTTNBP2 PRICKLE1 CC2D1A TSC2 ARHGEF15 NEDD9 DACT1 FCGR2B FARP1 ROCK1 KIF5B	2.94e-05	387	176	13	GO:0050807
GeneOntologyBiologicalProcess	regulation of postsynapse organization	DOCK1 LRFN1 PRICKLE1 CC2D1A TSC2 ARHGEF15 NEDD9 DACT1 FCGR2B	3.10e-05	185	176	9	GO:0099175
GeneOntologyBiologicalProcess	regulation of synapse structure or activity	DOCK1 LRFN1 CTTNBP2 PRICKLE1 CC2D1A TSC2 ARHGEF15 NEDD9 DACT1 FCGR2B FARP1 ROCK1 KIF5B	3.63e-05	395	176	13	GO:0050803
GeneOntologyBiologicalProcess	B cell receptor signaling pathway	IGLC7 CD19 FCGR2B IGLC1 IGLC3 IGLC6	5.88e-05	79	176	6	GO:0050853
GeneOntologyBiologicalProcess	immune response-activating cell surface receptor signaling pathway	RC3H1 LCP2 WNK1 OPRPN PRAM1 IGLC7 CD19 FCGR2B NECTIN2 IGLC1 IGLC3 IGLC6	6.29e-05	359	176	12	GO:0002429
GeneOntologyBiologicalProcess	negative regulation of developmental process	HSPG2 PDCD1 TOB2 LILRB3 PDE3B TRIO PRICKLE1 RC3H1 PARP3 TSC2 ADGRV1 MED1 ARHGEF15 NRP1 TFRC NCOR2 SEMA6D FCGR2B ATXN2 TJP2 ROCK1 ZFHX3 NKX3-1 PROX1	1.14e-04	1220	176	24	GO:0051093
GeneOntologyBiologicalProcess	leukocyte mediated immunity	PDCD1 PARP3 TFRC PRAM1 FCGR2C MAVS IGLC7 CD19 FCGR2B NECTIN2 IGLC1 IGLC2 IGLC3 IGLC6 KIF5B	1.31e-04	576	176	15	GO:0002443
GeneOntologyBiologicalProcess	lymphocyte mediated immunity	PDCD1 PARP3 TFRC FCGR2C IGLC7 CD19 FCGR2B NECTIN2 IGLC1 IGLC2 IGLC3 IGLC6 KIF5B	1.32e-04	449	176	13	GO:0002449
GeneOntologyBiologicalProcess	negative regulation of cellular component organization	HSPG2 APC2 TSC2 ARHGEF15 NRP1 TFRC RHPN1 DACT1 OSM SEMA6D FCGR2B ATXN2 TRIM9 ROCK1 TNFRSF1A RUBCN FKBP4 SLX4 PIF1	1.54e-04	864	176	19	GO:0051129
GeneOntologyBiologicalProcess	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	PDCD1 RC3H1 PARP3 TFRC FCGR2C IGLC7 CD19 FCGR2B NECTIN2 IGLC1 IGLC2 IGLC3 IGLC6	1.75e-04	462	176	13	GO:0002460
GeneOntologyBiologicalProcess	beta-catenin-TCF complex assembly	DACT1 KMT2D	2.16e-04	3	176	2	GO:1904837
GeneOntologyBiologicalProcess	acute inflammatory response	F12 TFR2 TFRC FCGR2C OSM FCGR2B CREB3L3	2.31e-04	143	176	7	GO:0002526
GeneOntologyBiologicalProcess	cell junction organization	DOCK1 LRFN1 CTTNBP2 PRICKLE1 PCLO CC2D1A TSC2 GRM6 GDNF ARHGEF15 NRP1 NEDD9 OPRPN RHPN1 DACT1 FCGR2B FARP1 TJP2 ROCK1 KIF5B	2.54e-04	974	176	20	GO:0034330
GeneOntologyBiologicalProcess	endocytosis	DOCK1 FKBP15 HSPG2 PDLIM7 TSC2 DENND1C TFR2 TFRC FCGR2C EPS15L1 FCGR2B ATXN2 KCNQ2 ROCK1 NEURL1B MYO15A RUBCN XKR5	2.62e-04	827	176	18	GO:0006897
GeneOntologyBiologicalProcess	positive regulation of protein metabolic process	MAP2K4 PRICKLE1 NELFA RPS6KB1 RPS6KB2 TAB2 LARP1B FANCM RFPL1 GDNF F12 TFR2 NRP1 TFRC NEDD9 DACT1 NCOR2 OSM TTBK1 MAVS NKX3-1 TNFRSF1A PRKAG2 ST18 WNK3 PROX1	2.77e-04	1458	176	26	GO:0051247
GeneOntologyCellularComponent	IgD immunoglobulin complex	IGLC7 IGLC1 IGLC3 IGLC6	8.05e-08	6	181	4	GO:0071738
GeneOntologyCellularComponent	IgE immunoglobulin complex	IGLC7 IGLC1 IGLC3 IGLC6	8.05e-08	6	181	4	GO:0071742
GeneOntologyCellularComponent	IgG immunoglobulin complex	IGLC7 IGLC1 IGLC2 IGLC3 IGLC6	8.65e-08	14	181	5	GO:0071735
GeneOntologyCellularComponent	IgA immunoglobulin complex	IGLC7 IGLC1 IGLC3 IGLC6	6.89e-06	15	181	4	GO:0071745
GeneOntologyCellularComponent	IgM immunoglobulin complex	IGLC7 IGLC1 IGLC3 IGLC6	6.89e-06	15	181	4	GO:0071753
GeneOntologyCellularComponent	postsynapse	DOCK1 NCOA2 LRFN1 CTTNBP2 TRIO PRICKLE1 PCLO RPS6KB1 APC2 TSC2 GRM6 ARHGEF15 TFR2 NRP1 TFRC PRR12 DACT1 GRID2IP FCGR2B FARP1 KIF5B	2.05e-04	1018	181	21	GO:0098794
Domain	GDS_CDC24_CS	TRIO OBSCN ARHGEF11 ARHGEF15 FARP1	2.64e-05	39	170	5	IPR001331
Domain	Ataxin-2_C	TOB2 GSPT2 ATXN2	5.98e-05	9	170	3	IPR009818
Domain	PAM2	TOB2 GSPT2 ATXN2	5.98e-05	9	170	3	PF07145
Domain	PDZ	PDLIM7 PCLO SIPA1L3 ARHGEF11 RHPN1 GRID2IP TJP2 PDZD4	7.36e-05	151	170	8	PS50106
Domain	PDZ	PDLIM7 PCLO SIPA1L3 ARHGEF11 RHPN1 GRID2IP TJP2 PDZD4	7.70e-05	152	170	8	IPR001478
Domain	Spt20	SUPT20H SUPT20HL2	8.24e-05	2	170	2	IPR021950
Domain	Ribosomal_S6_kinase	RPS6KB1 RPS6KB2	8.24e-05	2	170	2	IPR016238
Domain	Spt20	SUPT20H SUPT20HL2	8.24e-05	2	170	2	PF12090
Domain	SH3	DOCK1 TRIO OBSCN PPP1R13B NEDD9 PRAM1 ASAP2 TJP2 MYO15A	1.66e-04	216	170	9	SM00326
Domain	SH3	DOCK1 TRIO OBSCN PPP1R13B NEDD9 PRAM1 ASAP2 TJP2 MYO15A	1.66e-04	216	170	9	PS50002
Domain	SH3_domain	DOCK1 TRIO OBSCN PPP1R13B NEDD9 PRAM1 ASAP2 TJP2 MYO15A	1.90e-04	220	170	9	IPR001452
Domain	DH_1	TRIO OBSCN ARHGEF11 ARHGEF15 FARP1	2.70e-04	63	170	5	PS00741
Domain	PDZ	PDLIM7 SIPA1L3 ARHGEF11 RHPN1 GRID2IP TJP2 PDZD4	3.11e-04	141	170	7	PF00595
Domain	HMG_box_dom	SOX30 CIC KMT2D WDHD1 PROX1	3.13e-04	65	170	5	IPR009071
Domain	Pkinase_C	RPS6KB1 RPS6KB2 SGK2 ROCK1	3.46e-04	37	170	4	IPR017892
Domain	RhoGEF	TRIO OBSCN ARHGEF11 ARHGEF15 FARP1	3.86e-04	68	170	5	SM00325
Domain	PDZ	PDLIM7 SIPA1L3 ARHGEF11 RHPN1 GRID2IP TJP2 PDZD4	4.17e-04	148	170	7	SM00228
Domain	Ser/Thr_kinase_AS	MAP2K4 TRIO SPEG RPS6KB1 RPS6KB2 OBSCN WNK1 SGK2 TTBK1 ROCK1 WNK3	4.41e-04	357	170	11	IPR008271
Domain	RhoGEF	TRIO OBSCN ARHGEF11 ARHGEF15 FARP1	4.42e-04	70	170	5	PF00621
Domain	DH_2	TRIO OBSCN ARHGEF11 ARHGEF15 FARP1	4.42e-04	70	170	5	PS50010
Domain	-	PDLIM7 SIPA1L3 ARHGEF11 RHPN1 GRID2IP TJP2 PDZD4	4.52e-04	150	170	7	2.30.42.10
Domain	S_TKc	MAP2K4 TRIO SPEG RPS6KB1 RPS6KB2 OBSCN WNK1 SGK2 TTBK1 ROCK1 WNK3	4.62e-04	359	170	11	SM00220
Domain	-	TRIO OBSCN ARHGEF11 ARHGEF15 FARP1	4.72e-04	71	170	5	1.20.900.10
Domain	DH-domain	TRIO OBSCN ARHGEF11 ARHGEF15 FARP1	4.72e-04	71	170	5	IPR000219
Domain	PROTEIN_KINASE_ST	MAP2K4 TRIO SPEG RPS6KB1 RPS6KB2 OBSCN WNK1 SGK2 TTBK1 ROCK1 WNK3	4.95e-04	362	170	11	PS00108
Domain	Pkinase_C	RPS6KB1 RPS6KB2 SGK2 ROCK1	5.66e-04	42	170	4	PF00433
Domain	Pkinase	MAP2K4 TRIO SPEG RPS6KB1 RPS6KB2 OBSCN WNK1 SGK2 TTBK1 ROCK1 WNK3	7.55e-04	381	170	11	PF00069
Domain	OSR1_C	WNK1 WNK3	1.21e-03	6	170	2	PF12202
Domain	Kinase_OSR1/WNK_CCT	WNK1 WNK3	1.21e-03	6	170	2	IPR024678
Domain	TFR_dimer	TFR2 TFRC	1.21e-03	6	170	2	PF04253
Domain	-	TFR2 TFRC	1.21e-03	6	170	2	1.20.930.40
Domain	HMG	SOX30 CIC KMT2D WDHD1	1.47e-03	54	170	4	SM00398
Domain	-	SOX30 CIC KMT2D WDHD1	1.57e-03	55	170	4	1.10.30.10
Domain	CUE	AUP1 TAB2	1.68e-03	7	170	2	SM00546
Domain	TFR-like_dimer_dom	TFR2 TFRC	1.68e-03	7	170	2	IPR007365
Domain	IG	HSPG2 PDCD1 LILRB3 LRFN1 TRIO SPEG OBSCN LILRA6 CD19 FCGR2B NECTIN2	1.68e-03	421	170	11	SM00409
Domain	Ig_sub	HSPG2 PDCD1 LILRB3 LRFN1 TRIO SPEG OBSCN LILRA6 CD19 FCGR2B NECTIN2	1.68e-03	421	170	11	IPR003599
Domain	AGC-kinase_C	RPS6KB1 RPS6KB2 SGK2 ROCK1	1.68e-03	56	170	4	IPR000961
Domain	AGC_KINASE_CTER	RPS6KB1 RPS6KB2 SGK2 ROCK1	1.68e-03	56	170	4	PS51285
Domain	S_TK_X	RPS6KB1 RPS6KB2 SGK2 ROCK1	1.68e-03	56	170	4	SM00133
Domain	IG_LIKE	HSPG2 PDCD1 LILRB3 LRFN1 TRIO SPEG OBSCN LILRA6 CD19 FCGR2B NECTIN2 IGLC3	1.83e-03	491	170	12	PS50835
Pathway	REACTOME_RHOA_GTPASE_CYCLE	TRIO OBSCN ARHGEF11 ARHGEF15 TFRC RHPN1 FARP1 TJP2 ROCK1	5.36e-06	142	127	9	MM15576
Pathway	REACTOME_RHOA_GTPASE_CYCLE	TRIO OBSCN ARHGEF11 ARHGEF15 TFRC RHPN1 FARP1 TJP2 ROCK1	7.94e-06	149	127	9	M41805
Pathway	PID_RHOA_REG_PATHWAY	TRIO OBSCN ARHGEF11 ARHGEF15 FARP1	5.59e-05	46	127	5	M68
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 HSPG2 FLNC LRFN1 ZNF628 TRIO SPEG SIPA1L3 OBSCN CC2D1A TSC2 KDM6B ARHGEF11 WNK1 CIC FAM83H HIVEP3 PRR12 RHPN1 DACT1 NCOR2 EPS15L1 TNRC18 KMT2D KLF10 EHMT1 KCNQ2 MLLT1 MICAL3 SPEN PRRT4 ZNF687	4.06e-15	1105	183	32	35748872
Pubmed	Human transcription factor protein interaction networks.	NCOA2 HSPG2 CEP85 SUPT20H RC3H1 NACA PPP1R13B CC2D1A PROSER1 EWSR1 MAP7 CIC TFRC MRPS18A PRR12 NCOR2 ARID1B KMT2D KLF10 ATXN2 TRIM9 TLE3 EHMT1 MLLT1 ZFHX3 YY1AP1 MGA SPEN FKBP4 SLX4 ZNF687 PYGO1	4.12e-12	1429	183	32	35140242
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOA2 FKBP15 MAP2K4 LRFN1 ZNF219 CTTNBP2 TRIO PRR36 RPS6KB1 SIPA1L3 APC2 TSC2 EWSR1 ARHGEF11 NCOR2 EPS15L1 ATXN2 FARP1 EHMT1 ROCK1 KIF5B MTCL1 MGA WNK3 PROX1	5.59e-11	963	183	25	28671696
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	DOCK1 TOB2 PDLIM7 APC2 PEX14 WNK1 CIC NEDD9 NCOR2 TNRC18 ASAP2 GSPT2 ATXN2 AFF1 MAML2 MGA SPEN	1.56e-10	430	183	17	35044719
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA2 FAT4 ZNF142 ZNF219 AUP1 PRICKLE1 USP24 TAB2 MED1 SEC31B CIC NCOR2 ARID1B KMT2D WDHD1 TLE3 EHMT1 MTCL1 SPEN ZNF687	2.13e-10	638	183	20	31182584
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA2 MED1 CIC PRR12 NCOR2 ARID1B KMT2D TLE3 SPEN	5.97e-10	83	183	9	28794006
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	DOCK1 NELFA RPS6KB1 USP24 CC2D1A MED1 MAP7 WNK1 EPS15L1 KLF10 MAVS TLE3 TJP2 MTCL1 SPEN FKBP4 ZNF687	1.69e-09	503	183	17	16964243
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DOCK1 NCOA2 ZNF704 PDE3B TRIO RPS6KB1 SIPA1L3 OBSCN PEX14 ADGRV1 SNX29 NRP1 SGK2 HIVEP3 NCOR2 EPS15L1 TNRC18 ASAP2 ATXN2 FARP1 TLE3 NECTIN2 EHMT1 AFF1 ZFHX3 MICAL3 PRKAG2 PACRG	5.18e-09	1489	183	28	28611215
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SLAIN2 RAPH1 TRIO PDLIM7 RPS6KB1 SIPA1L3 PPP1R13B TAB2 CC2D1A ARHGEF11 FAM83H EPS15L1 MAVS MTUS1 FARP1 TJP2 MICAL3 KIF5B ZNF598 MGA FKBP4	5.49e-09	853	183	21	28718761
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA2 PROSER1 TFRC PRR12 NCOR2 ARID1B TNRC18 KMT2D TLE3 EHMT1 ZFHX3 MGA SPEN SLX4	6.15e-09	351	183	14	38297188
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 SLAIN2 CEP85 RAPH1 PDLIM7 USP24 PPP1R13B CC2D1A MED1 EPS15L1 ARID1B KMT2D TJP2 KIF5B ZNF598 MGA SPEN	6.21e-09	549	183	17	38280479
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SLAIN2 PDE3B RAPH1 TRIO SIPA1L3 TAB2 CC2D1A TSC2 LARP1B MAP7 WNK1 CIC FAM83H MTUS1 TRIM9 NECTIN2 TJP2 KIF5B MTCL1 ZNF598 WNK3	6.46e-09	861	183	21	36931259
Pubmed	Structure and function of immunoglobulins.	IGLC7 IGLC1 IGLC2 IGLC3 IGLC6	1.10e-08	15	183	5	20176268
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOA2 CEP85 AUP1 RC3H1 EWSR1 CIC FAM83H PRR12 NCOR2 ARID1B KMT2D ATXN2 TLE3 SNRPC FKBP4	2.35e-08	457	183	15	32344865
Pubmed	Human immunoglobulin C lambda 6 gene encodes the Kern+Oz-lambda chain and C lambda 4 and C lambda 5 are pseudogenes.	IGLC1 IGLC2 IGLC3 IGLC6	5.11e-08	8	183	4	3122211
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CTTNBP2 RC3H1 SIPA1L3 USP37 FANCM WNK1 ARHGEF15 HIVEP3 PRR12 TNRC18 ASAP2 TTBK1 MICAL3 MGA SLX4	6.32e-08	493	183	15	15368895
Pubmed	Structure and expression of the human immunoglobulin lambda genes.	IGLC7 IGLC1 IGLC2 IGLC3	9.16e-08	9	183	4	2115572
Pubmed	Clustered arrangement of immunoglobulin lambda constant region genes in man.	IGLC1 IGLC2 IGLC3 IGLC6	9.16e-08	9	183	4	6273747
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	NCOA2 SLAIN2 FLNC SUPT20H NELFA MED1 NCOR2 EPS15L1 KLF10 MAVS TLE3 KIF5B MGA SLX4	1.14e-07	444	183	14	34795231
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	NCOA2 CEP85 RC3H1 PROSER1 EWSR1 CIC PRR12 NCOR2 SNRPC	1.25e-07	152	183	9	38360978
Pubmed	Specific interaction between S6K1 and CoA synthase: a potential link between the mTOR/S6K pathway, CoA biosynthesis and energy metabolism.	RPS6KB1 RPS6KB2 COASY	1.43e-07	3	183	3	15589845
Pubmed	Unraveling of the polymorphic C lambda 2-C lambda 3 amplification and the Ke+Oz- polymorphism in the human Ig lambda locus.	IGLC1 IGLC2 IGLC3	1.43e-07	3	183	3	12077254
Pubmed	Three-dimensional structure of a light chain dimer crystallized in water. Conformational flexibility of a molecule in two crystal forms.	IGLC1 IGLC2 IGLC3	1.43e-07	3	183	3	2515285
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	NCOA2 MED1 NCOR2 ARID1B KMT2D TLE3 SPEN	1.92e-07	78	183	7	28611094
Pubmed	Recognition of immunoglobulins by Fcgamma receptors.	IGLC7 FCGR2B IGLC1 IGLC2 IGLC3 IGLC6	2.00e-07	48	183	6	11955599
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	NCOA2 SUPT20H PCLO PRR12 NCOR2 ARID1B TNRC18 KMT2D TLE3 ROCK1 YY1AP1 MYO15A MGA	2.20e-07	398	183	13	35016035
Pubmed	A human MAP kinase interactome.	DOCK1 FLNC ZNF142 SUPT20H PPP1R13B LCP2 ARHGEF11 WNK1 CIC ASAP2 YY1AP1 KIF5B MGA PYGO1	3.41e-07	486	183	14	20936779
Pubmed	S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3.	RPS6KB1 RPS6KB2 MAVS TNFRSF1A	3.55e-07	12	183	4	27043414
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOA2 SLAIN2 CEBPD NELFA CC2D1A EWSR1 MED1 CIC PRR12 PRAM1 NCOR2 ARID1B TNRC18 KMT2D ATXN2 TLE3 EHMT1 KIF5B SPEN FKBP4 ZNF687	4.14e-07	1103	183	21	34189442
Pubmed	The three-dimensional structure of the fab' fragment of a human myeloma immunoglobulin at 2.0-angstrom resolution.	IGLC1 IGLC2 IGLC3	5.71e-07	4	183	3	4215080
Pubmed	Immunoglobulin lambda-chains. The complete amino acid sequence of a Bence-Jones protein.	IGLC1 IGLC2 IGLC3	5.71e-07	4	183	3	4883841
Pubmed	Comparative studies on the structure of the light chains of human immunoglobulins. IV. Assignment of a subsubgroup.	IGLC1 IGLC2 IGLC3	5.71e-07	4	183	3	6404900
Pubmed	Primary structure of the Mcg lambda chain.	IGLC1 IGLC2 IGLC3	5.71e-07	4	183	3	4415202
Pubmed	[Structural rule of antibodies. Primary structure of a monoclonal immunoglobulin-L-chain of the lambda type, subgroup IV (Bence-Jones-protein Kern). V. The complete amino acid sequence and its genetic interpretation].	IGLC1 IGLC2 IGLC3	5.71e-07	4	183	3	5549568
Pubmed	Functional proteomics mapping of a human signaling pathway.	HSPG2 FLNC AUP1 PDLIM7 PPP1R13B EWSR1 NEDD9 NCOR2 ARID1B KMT2D KLF10 AFF1 ROCK1 MGA RUBCN	6.36e-07	591	183	15	15231748
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RAPH1 NELFA USP24 MED1 CIC NCOR2 EPS15L1 KMT2D WDHD1 TLE3 TJP2 AFF1 YY1AP1 MICAL3 COASY SPEN ZNF687	8.25e-07	774	183	17	15302935
Pubmed	Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.	SIPA1L3 TFRC OPRPN MTUS1 IGLC1 IGLC2 IGLC3 PRKAG2	1.33e-06	149	183	8	22664934
Pubmed	Amino acid sequence of the (lambda) light chain of a human myeloma immunoglobulin (IgG New).	IGLC1 IGLC2 IGLC3	1.42e-06	5	183	3	4814727
Pubmed	The amino acid sequence of a lambda type Bence-Jones protein. 3. The complete amino acid sequence and the location of the disulfide bridges.	IGLC1 IGLC2 IGLC3	1.42e-06	5	183	3	4909564
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	CEP85 RAPH1 TRIO NACA PEX14 MED1 CIC TFRC ARID1B TLE3 NECTIN2 MLLT1 ZNF687	1.49e-06	472	183	13	38943005
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	SLAIN2 CEP85 AUP1 PDLIM7 NELFA RPS6KB1 SIPA1L3 NACA TAB2 CC2D1A EWSR1 FAM83H TFRC EPS15L1 WDHD1 MAVS ATXN2 NECTIN2 ZNF598	1.74e-06	1007	183	19	34597346
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA2 NELFA MED1 CIC PRR12 ARID1B TNRC18 KMT2D TLE3 MGA	1.75e-06	268	183	10	33640491
Pubmed	Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice.	FLNC TFR2 SGK2 ADGRG2 EHMT1	1.90e-06	39	183	5	24703692
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	SLAIN2 HSPG2 FLNC CTTNBP2 TRIO OBSCN TAB2 WNK1 NEDD9 DACT1 ARID1B KLF10 MGA	2.62e-06	497	183	13	23414517
Pubmed	Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats.	ARID1B KMT2D ATXN2	2.83e-06	6	183	3	8896557
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CEP85 RAPH1 TRIO PDLIM7 SIPA1L3 PPP1R13B TAB2 CIC NCOR2 ARID1B KMT2D MTUS1 ATXN2 FARP1 TLE3 NECTIN2 ROCK1 MICAL3 FKBP4	3.15e-06	1049	183	19	27880917
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	HSPG2 FAT4 SUPT20H PDLIM7 EWSR1 WNK1 CIC ATXN2 IGLC1 YY1AP1 CACNA1G CREB3L3 SPEN PDZD4	4.68e-06	608	183	14	16713569
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	FKBP15 CEP85 CTTNBP2 PDLIM7 NELFA SIPA1L3 PPP1R13B TSC2 WNK1 ARID1B TJP2 MTCL1	4.83e-06	446	183	12	24255178
Pubmed	Physicochemical and functional characterization of the C1r subunit of the first complement component.	IGLC7 IGLC1 IGLC2 IGLC3 IGLC6	4.90e-06	47	183	5	814163
Pubmed	cDNAs with long CAG trinucleotide repeats from human brain.	NCOR2 TNRC18 KMT2D ATXN2	6.07e-06	23	183	4	9225980
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	SLAIN2 CEP85 SIPA1L3 PRR12 NCOR2 KMT2D MGA SPEN	6.40e-06	184	183	8	32908313
Pubmed	Foxc2 is essential for podocyte function.	GDNF NRP1 RHPN1 NPHS2	7.26e-06	24	183	4	31062503
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	SUPT20H NELFA MED1 ARID1B TLE3 MGA SPEN	7.44e-06	134	183	7	25452129
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	FLNC CEP85 PDLIM7 RC3H1 CC2D1A LARP1B MED1 ATXN2 FARP1 EHMT1 TJP2 C1orf122 ZNF598 MGA SPEN	7.53e-06	724	183	15	36232890
Pubmed	Characterization of the two unique human anti-flavin monoclonal immunoglobulins.	IGLC1 IGLC2 IGLC3	7.87e-06	8	183	3	7737190
Pubmed	Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes.	NCOA2 MED1 NCOR2	7.87e-06	8	183	3	23178929
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FKBP15 TOB2 SPEG SEMA6D TLE3 YY1AP1 MICAL3 MTCL1 SPEN ST18 RUBCN	1.16e-05	407	183	11	12693553
Pubmed	Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapy.	SUPT20HL2 OPRPN IGLC1 IGLC2 IGLC3 IGLC6	1.22e-05	96	183	6	23580065
Pubmed	Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action.	NCOA2 MED1 NCOR2 FKBP4	1.38e-05	28	183	4	24880616
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RAPH1 USP24 CIC PRR12 NCOR2 KMT2D TLE3 ZFHX3 MGA ZNF687 PROX1	1.49e-05	418	183	11	34709266
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	NCOA2 CEP85 SUPT20H PPP1R13B TAB2 MAP7 WNK1 CIC NCOR2 ROCK1 YY1AP1 SPEN SLX4	1.58e-05	588	183	13	38580884
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TRIO SIPA1L3 LARP1B MAP7 SNX29 MTUS1 MICAL3 MTCL1	1.62e-05	209	183	8	36779422
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	OBSCN USP37 FANCM HIVEP3 TLE3 WNK3	1.64e-05	101	183	6	10997877
Pubmed	The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins.	RPS6KB1 RPS6KB2 TSC2	1.67e-05	10	183	3	15249583
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	FLNC MAP2K4 NACA CC2D1A EPS15L1 GSPT2 TJP2 MICAL3 KIF5B PROX1	2.31e-05	360	183	10	33111431
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SIPA1L3 TAB2 ADGRV1 WNK1 ARHGEF15 TRIM9 EHMT1 CACNA1G	2.74e-05	225	183	8	12168954
Pubmed	Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.	TFR2 TFRC	2.75e-05	2	183	2	15987753
Pubmed	Activation of Mechanistic Target of Rapamycin (mTOR) in Human Endothelial Cells Infected with Pathogenic Spotted Fever Group Rickettsiae.	RPS6KB1 RPS6KB2	2.75e-05	2	183	2	33003310
Pubmed	Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium.	FCGR2C FCGR2B	2.75e-05	2	183	2	2531080
Pubmed	Structural and functional insight into regulation of kinesin-1 by microtubule-associated protein MAP7.	MAP7 KIF5B	2.75e-05	2	183	2	35050657
Pubmed	Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure.	FLNC TRIO	2.75e-05	2	183	2	16914736
Pubmed	A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells.	TFR2 TFRC	2.75e-05	2	183	2	21849092
Pubmed	Different interactomes for p70-S6K1 and p54-S6K2 revealed by proteomic analysis.	RPS6KB1 RPS6KB2	2.75e-05	2	183	2	27493124
Pubmed	Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens.	PDCD1 CD19	2.75e-05	2	183	2	22003198
Pubmed	ATXN2-mediated translation of TNFR1 promotes esophageal squamous cell carcinoma via m6A-dependent manner.	ATXN2 TNFRSF1A	2.75e-05	2	183	2	34995801
Pubmed	S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase.	RPS6KB1 RPS6KB2	2.75e-05	2	183	2	17550782
Pubmed	Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity.	RPS6KB1 RPS6KB2	2.75e-05	2	183	2	18174371
Pubmed	The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.	KMT2D CD19	2.75e-05	2	183	2	26366710
Pubmed	Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population.	LILRB3 LILRA6	2.75e-05	2	183	2	33526815
Pubmed	Regulation of Na+-K+-Cl- cotransporter type 2 by the with no lysine kinase-dependent signaling pathway.	WNK1 WNK3	2.75e-05	2	183	2	30917032
Pubmed	Gammaherpesvirus-mediated repression reveals EWSR1 to be a negative regulator of B cell responses.	EWSR1 CD19	2.75e-05	2	183	2	35921433
Pubmed	Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase.	RPS6KB1 RPS6KB2	2.75e-05	2	183	2	9822608
Pubmed	MAP and kinesin-dependent nuclear positioning is required for skeletal muscle function.	MAP7 KIF5B	2.75e-05	2	183	2	22425998
Pubmed	Immunohistochemical demonstration of transferrin receptor 1 and 2 in human hepatocellular carcinoma tissue.	TFR2 TFRC	2.75e-05	2	183	2	24901155
Pubmed	Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer.	RPS6KB1 RPS6KB2	2.75e-05	2	183	2	20953835
Pubmed	A disputed evidence on obesity: comparison of the effects of Rcan2(-/-) and Rps6kb1(-/-) mutations on growth and body weight in C57BL/6J mice.	RPS6KB1 RCAN2	2.75e-05	2	183	2	27604858
Pubmed	Metabolic control by S6 kinases depends on dietary lipids.	RPS6KB1 RPS6KB2	2.75e-05	2	183	2	22412899
Pubmed	Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19.	CD19 FCGR2B	2.75e-05	2	183	2	24828435
Pubmed	Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans.	LILRB3 LILRA6	2.75e-05	2	183	2	36449053
Pubmed	A novel FLNC frameshift and an OBSCN variant in a family with distal muscular dystrophy.	FLNC OBSCN	2.75e-05	2	183	2	29073160
Pubmed	Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway.	RPS6KB1 RPS6KB2	2.75e-05	2	183	2	18758466
Pubmed	Orthologous relationship of obscurin and Unc-89: phylogeny of a novel family of tandem myosin light chain kinases.	SPEG OBSCN	2.75e-05	2	183	2	15185077
Pubmed	Heterotypic interactions between transferrin receptor and transferrin receptor 2.	TFR2 TFRC	2.75e-05	2	183	2	12406888
Pubmed	MAP7 interacts with RC3H1 and cooperatively regulate cell-cycle progression of cervical cancer cells via activating the NF-κB signaling.	RC3H1 MAP7	2.75e-05	2	183	2	32446391
Pubmed	Transmembrane adaptor protein PAG is a mediator of PD-1 inhibitory signaling in human T cells.	PDCD1 PAG1	2.75e-05	2	183	2	34083754
Pubmed	Functions and regulation of the 70kDa ribosomal S6 kinases.	RPS6KB1 RPS6KB2	2.75e-05	2	183	2	20932932
Pubmed	CD19 and CD32b differentially regulate human B cell responsiveness.	CD19 FCGR2B	2.75e-05	2	183	2	24442430
Pubmed	Unique and Redundant Functions of p70 Ribosomal S6 Kinase Isoforms Regulate Mesenchymal Cell Proliferation and Migration in Pulmonary Fibrosis.	RPS6KB1 RPS6KB2	2.75e-05	2	183	2	27438654
Pubmed	Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene.	FCGR2C FCGR2B	2.75e-05	2	183	2	9516136
Pubmed	Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients.	LILRB3 LILRA6	2.75e-05	2	183	2	19617579
Interaction	NUP35 interactions	NCOA2 CEP85 AUP1 RC3H1 PEX14 EWSR1 CIC FAM83H NRP1 HIVEP3 PRR12 NCOR2 ARID1B KMT2D MAVS ATXN2 TLE3 SNRPC FKBP4	8.18e-09	424	179	19	int:NUP35
Interaction	TOP3B interactions	VWA5B2 HSPG2 FLNC LRFN1 ZNF628 TRIO SPEG SIPA1L3 OBSCN CC2D1A TSC2 KDM6B ARHGEF11 WNK1 CIC FAM83H HIVEP3 PRR12 RHPN1 DACT1 NCOR2 EPS15L1 TNRC18 KMT2D KLF10 ATXN2 EHMT1 KCNQ2 MLLT1 MICAL3 ZNF598 SPEN PRRT4 ZNF687	2.20e-07	1470	179	34	int:TOP3B
Interaction	PAX9 interactions	NCOA2 PROSER1 EWSR1 CIC PRR12 NCOR2 ARID1B KMT2D TLE3 ZFHX3	2.52e-07	130	179	10	int:PAX9
Interaction	FEV interactions	NCOA2 SUPT20H CIC PRR12 NCOR2 ARID1B KMT2D TLE3 EHMT1 ZFHX3 YY1AP1 MGA	2.81e-07	203	179	12	int:FEV
Interaction	SOX7 interactions	NCOA2 EWSR1 PRR12 NCOR2 ARID1B TNRC18 KMT2D TLE3	6.74e-07	82	179	8	int:SOX7
Interaction	TBR1 interactions	NCOA2 PROSER1 CIC PRR12 NCOR2 ARID1B KMT2D TLE3 ZFHX3	7.60e-07	113	179	9	int:TBR1
Interaction	IRF4 interactions	OTUD1 CIC PRR12 NCOR2 ARID1B KMT2D FKBP4 PROX1	8.90e-07	85	179	8	int:IRF4
Interaction	HNF1B interactions	NCOA2 PROSER1 EWSR1 CIC PRR12 NCOR2 ARID1B KMT2D TLE3 ZFHX3 MGA	1.10e-06	190	179	11	int:HNF1B
Interaction	GSK3B interactions	CEBPD TRIO SIPA1L3 PARP3 NACA TAB2 TSC2 EWSR1 LARP1B MAP7 ARHGEF11 SNX29 TFRC MTUS1 TLE3 MICAL3 KIF5B MTCL1 CREB3L3 ZNF598 FKBP4 SLX4 RCAN2	2.84e-06	868	179	23	int:GSK3B
Interaction	CRX interactions	NCOA2 PROSER1 PRR12 NCOR2 ARID1B TNRC18 KMT2D TLE3 EHMT1 ZFHX3 MGA SPEN	2.99e-06	254	179	12	int:CRX
Interaction	EGR2 interactions	NCOA2 PROSER1 PRR12 NCOR2 ARID1B TNRC18 KMT2D TLE3 ZFHX3 MGA	3.12e-06	171	179	10	int:EGR2
Interaction	TLX1 interactions	NCOA2 CIC PRR12 NCOR2 ARID1B KMT2D TLE3 EHMT1 ZFHX3 PYGO1	3.84e-06	175	179	10	int:TLX1
Interaction	PAX8 interactions	NCOA2 PROSER1 CIC PRR12 NCOR2 ARID1B KMT2D TLE3	6.71e-06	111	179	8	int:PAX8
Interaction	HNF4A interactions	NCOA2 MED1 CIC PRR12 NCOR2 ARID1B KMT2D EHMT1 MGA SPEN SLX4 PROX1	6.74e-06	275	179	12	int:HNF4A
Interaction	TBXT interactions	NCOA2 CIC PRR12 NCOR2 ARID1B KMT2D TLE3 SPEN	9.30e-06	116	179	8	int:TBXT
Interaction	PAX2 interactions	CIC PRR12 NCOR2 ARID1B KMT2D TLE3 MGA	1.07e-05	85	179	7	int:PAX2
Interaction	BAG2 interactions	VWA5B2 NCOA2 FKBP15 RC3H1 OTUD1 RPS6KB2 PPP1R13B TAB2 WNK1 CIC TFRC NPHS2 WDHD1 MAVS KCNQ2 ZNF598 SPEN WNK3	1.14e-05	622	179	18	int:BAG2
Interaction	GSC interactions	PRR12 NCOR2 ARID1B TNRC18 KMT2D TLE3 ZFHX3	1.25e-05	87	179	7	int:GSC
Interaction	PPIA interactions	FLNC CEP85 RAPH1 TRIO RC3H1 OTUD1 NACA PEX14 EWSR1 MED1 SEC31B CIC TFRC ARID1B MAVS TLE3 NECTIN2 MLLT1 COASY ZNF598 SLX4 ZNF687	1.36e-05	888	179	22	int:PPIA
Interaction	LHX4 interactions	NCOA2 CIC NCOR2 ARID1B KMT2D EHMT1 MGA ZNF687 PYGO1	1.80e-05	166	179	9	int:LHX4
Interaction	SP7 interactions	NCOA2 PROSER1 CIC PRR12 NCOR2 ARID1B KMT2D TLE3 EHMT1 MLLT1 MGA PYGO1	1.84e-05	304	179	12	int:SP7
Interaction	NR3C1 interactions	NCOA2 FAT4 ZNF142 ZNF219 AUP1 PRICKLE1 USP24 PEX14 TAB2 MED1 SEC31B CIC TFRC NCOR2 ARID1B KMT2D WDHD1 TLE3 EHMT1 MTCL1 SPEN FKBP4 ZNF687	1.84e-05	974	179	23	int:NR3C1
Interaction	SOX9 interactions	CIC PRR12 ARID1B KMT2D MAVS TLE3 SPEN	2.54e-05	97	179	7	int:SOX9
Interaction	TEAD1 interactions	CIC PRR12 NCOR2 ARID1B KMT2D TLE3 EHMT1 ZFHX3 MGA	2.86e-05	176	179	9	int:TEAD1
Interaction	GCM1 interactions	CIC PRR12 NCOR2 ARID1B KMT2D TLE3	3.13e-05	68	179	6	int:GCM1
Interaction	TLE3 interactions	NCOA2 PROSER1 CIC FAM83H PRR12 NCOR2 ARID1B TNRC18 KMT2D TLE3 ZFHX3 SPEN SNRPC	3.30e-05	376	179	13	int:TLE3
Interaction	NFIX interactions	CIC PRR12 NCOR2 ARID1B KMT2D TLE3 EHMT1 ZFHX3 MGA SPEN	3.70e-05	227	179	10	int:NFIX
Interaction	SOX15 interactions	NCOA2 CIC PRR12 NCOR2 ARID1B KMT2D TLE3 EHMT1	3.84e-05	141	179	8	int:SOX15
Interaction	LHX2 interactions	CIC NCOR2 ARID1B KMT2D EHMT1 ZFHX3 MGA ZNF687 PYGO1	3.89e-05	183	179	9	int:LHX2
Interaction	TLX2 interactions	CIC PRR12 NCOR2 ARID1B KMT2D TLE3 EHMT1 ZFHX3	4.04e-05	142	179	8	int:TLX2
Interaction	YWHAH interactions	NCOA2 SLAIN2 PDE3B TRIO SPEG SIPA1L3 RPS6KB2 TAB2 CC2D1A TSC2 LARP1B MED1 MAP7 WNK1 CIC FAM83H GRID2IP MTUS1 NECTIN2 TJP2 KIF5B MTCL1 RUBCN WNK3	4.40e-05	1102	179	24	int:YWHAH
Interaction	ANKFY1 interactions	DOCK1 SLAIN2 TRIO CC2D1A KDM6B SNX29 TFRC FARP1 ROCK1 ZNF598	5.14e-05	236	179	10	int:ANKFY1
Interaction	RHOB interactions	DOCK1 FAT4 PAG1 RAPH1 TRIO AUP1 SIPA1L3 SLC38A5 CC2D1A TSC2 ARHGEF11 SNX29 TFRC SEMA6D FARP1 NECTIN2 TJP2 ROCK1 MICAL3 COASY	6.01e-05	840	179	20	int:RHOB
Interaction	TLX3 interactions	NCOA2 PROSER1 CIC PRR12 NCOR2 ARID1B KMT2D TLE3 EHMT1 ZFHX3 ITIH6	6.11e-05	291	179	11	int:TLX3
Interaction	GSK3A interactions	TRIO SIPA1L3 EWSR1 LARP1B MAP7 ARHGEF11 SNX29 TNRC18 MTUS1 FCGR2B MICAL3 MTCL1 SLX4 RCAN2	7.20e-05	464	179	14	int:GSK3A
Interaction	GATA2 interactions	MED1 CIC PRR12 NCOR2 ARID1B KMT2D TLE3 EHMT1 ZFHX3	7.45e-05	199	179	9	int:GATA2
Interaction	CAMKV interactions	HSPG2 NRP1 TNRC18 FARP1 MLLT1 AFF1 SPEN	8.93e-05	118	179	7	int:CAMKV
Interaction	EYA2 interactions	CEP85 CIC NCOR2 ARID1B KMT2D TLE3 SNRPC	1.05e-04	121	179	7	int:EYA2
Interaction	AKT3 interactions	PDE3B RPS6KB1 OTUD1 RPS6KB2 SGK2 MICAL3	1.10e-04	85	179	6	int:AKT3
Interaction	NFIC interactions	CIC PRR12 NCOR2 ARID1B KMT2D TLE3 EHMT1 ROCK1 MGA	1.12e-04	210	179	9	int:NFIC
Interaction	PAX7 interactions	CIC PRR12 NCOR2 ARID1B KMT2D TLE3 ZFHX3	1.22e-04	124	179	7	int:PAX7
Interaction	ESRRB interactions	NCOA2 FKBP15 EWSR1 MED1 TFRC PRR12 KMT2D EHMT1 MGA ZNF687	1.22e-04	262	179	10	int:ESRRB
Interaction	SH3KBP1 interactions	SLAIN2 ZNF219 RAPH1 NELFA MAP7 NPHS2 TNRC18 ASAP2 ATXN2 TJP2 TNFRSF1A	1.23e-04	315	179	11	int:SH3KBP1
Interaction	TPRX2 interactions	NCOA2 PRR12 ARID1B KMT2D TLE3	1.38e-04	56	179	5	int:TPRX2
Interaction	MED23 interactions	NCOA2 SUPT20H MED1 MAP7 TLE3 ROCK1 ZFHX3 SPEN SLX4 ZNF687	1.38e-04	266	179	10	int:MED23
Interaction	PROSER1 interactions	PROSER1 EWSR1 MAP7 TLE3	1.57e-04	31	179	4	int:PROSER1
Interaction	TNIK interactions	FKBP15 ZNF219 CTTNBP2 TRIO PPP1R13B TAB2 EWSR1 NCOR2 EHMT1 KCNQ2 KIF5B MGA	1.60e-04	381	179	12	int:TNIK
Interaction	HSPA2 interactions	NCOA2 FKBP15 RC3H1 CC2D1A EWSR1 CIC F12 ARID1B WDHD1 MAVS KIF5B ZNF598 SPEN	1.61e-04	440	179	13	int:HSPA2
Interaction	SOX10 interactions	NCOA2 PROSER1 CIC NCOR2 ARID1B KMT2D	1.71e-04	92	179	6	int:SOX10
Interaction	SYNE3 interactions	PDE3B CEP85 PDLIM7 RC3H1 SIPA1L3 PPP1R13B TAB2 CC2D1A PROSER1 FAM83H TFRC NCOR2 ZNF598	1.76e-04	444	179	13	int:SYNE3
Interaction	ZNF326 interactions	FKBP15 RC3H1 EWSR1 MED1 USP37 CIC ARHGEF15 GSPT2 SNRPC	1.83e-04	224	179	9	int:ZNF326
Interaction	SOX17 interactions	NCOA2 CIC PRR12 NCOR2 ARID1B KMT2D	2.04e-04	95	179	6	int:SOX17
Interaction	KLF3 interactions	CIC TFRC NCOR2 ARID1B KMT2D TLE3 EHMT1 ZFHX3 MGA	2.08e-04	228	179	9	int:KLF3
Interaction	MAPRE3 interactions	SLAIN2 CTTNBP2 TRIO SIPA1L3 APC2 MAP7 TTBK1 MTUS1 ZNF598	2.22e-04	230	179	9	int:MAPRE3
Interaction	ALG13 interactions	NCOA2 RC3H1 PRR12 NCOR2 ARID1B KMT2D ATXN2 TLE3	2.37e-04	183	179	8	int:ALG13
Interaction	NINL interactions	CEP85 PDLIM7 SIPA1L3 NACA PPP1R13B CC2D1A EWSR1 FAM83H MTUS1 ZFHX3 MICAL3 IGLC2 ZNF598	2.38e-04	458	179	13	int:NINL
Interaction	LHX3 interactions	PRICKLE1 CIC PRR12 NCOR2 ARID1B KMT2D EHMT1 MGA	2.55e-04	185	179	8	int:LHX3
Interaction	DPPA4 interactions	PCLO RPS6KB1 NACA NEDD9 CDAN1 PRAM1 SPEN	2.58e-04	140	179	7	int:DPPA4
Interaction	NFIB interactions	CIC PRR12 NCOR2 ARID1B KMT2D TLE3 EHMT1	2.82e-04	142	179	7	int:NFIB
Interaction	NFIA interactions	NCOA2 CIC PRR12 NCOR2 ARID1B KMT2D TLE3 EHMT1	2.84e-04	188	179	8	int:NFIA
Interaction	ENTR1 interactions	CEP85 SIPA1L3 PPP1R13B PEX14 TAB2 CC2D1A TJP2 PRKAG2	2.84e-04	188	179	8	int:ENTR1
Interaction	CTBP1 interactions	ZNF219 PCLO RPS6KB1 EWSR1 MED1 CIC PRR12 NCOR2 KLF10 EHMT1 MAML2 SPEN	2.87e-04	406	179	12	int:CTBP1
Interaction	YWHAG interactions	SLAIN2 PDE3B RAPH1 SPEG RC3H1 SIPA1L3 USP24 TAB2 TSC2 EWSR1 LARP1B MAP7 USP37 WNK1 CIC FAM83H TTBK1 GRID2IP MTUS1 NECTIN2 TJP2 KIF5B MTCL1 RUBCN	2.93e-04	1248	179	24	int:YWHAG
Interaction	LHX1 interactions	SUPT20H NCOR2 ARID1B KMT2D EHMT1 MGA	3.17e-04	103	179	6	int:LHX1
Interaction	EYA4 interactions	NCOA2 CEP85 RC3H1 PROSER1 EWSR1 CIC PRR12 NCOR2 SNRPC	3.34e-04	243	179	9	int:EYA4
Interaction	MYOD1 interactions	NCOA2 PRR12 NCOR2 ARID1B KMT2D TLE3 EHMT1 MGA	3.51e-04	194	179	8	int:MYOD1
Interaction	AFF3 interactions	TFRC MLLT1 SLX4	3.54e-04	16	179	3	int:AFF3
Interaction	KLF5 interactions	NCOA2 CIC PRR12 NCOR2 ARID1B KMT2D TLE3 MGA	3.63e-04	195	179	8	int:KLF5
Interaction	ETV4 interactions	NCOA2 PRR12 NCOR2 ARID1B KMT2D	3.71e-04	69	179	5	int:ETV4
Interaction	WWTR1 interactions	NCOA2 SLAIN2 CEP85 RAPH1 PDLIM7 USP24 PPP1R13B EPS15L1 ARID1B KMT2D KIF5B ZNF598	4.06e-04	422	179	12	int:WWTR1
Interaction	MAD2L1 interactions	NCOA2 SUPT20H FANCM CIC PRR12 WDHD1 EHMT1 MGA SLX4	4.35e-04	252	179	9	int:MAD2L1
Interaction	ANK3 interactions	FLNC LILRB3 EPS15L1 TTBK1 FARP1 TLE3 KCNQ2 MICAL3	4.44e-04	201	179	8	int:ANK3
Interaction	LILRA6 interactions	LILRB3 LILRA6	4.65e-04	4	179	2	int:LILRA6
Interaction	TAFA5 interactions	FAT4 ADGRV1 DCBLD2	5.10e-04	18	179	3	int:TAFA5
Cytoband	22q11.2	IGLC7 IGLC1 IGLC2 IGLC3 IGLC6	1.25e-04	120	183	5	22q11.2
Cytoband	5q33	SOX30 F12	2.35e-04	6	183	2	5q33
GeneFamily	PDZ domain containing	PDLIM7 PCLO SIPA1L3 ARHGEF11 RHPN1 GRID2IP TJP2 PDZD4	1.06e-05	152	125	8	1220
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOR2 TNRC18 KMT2D ATXN2	2.46e-05	25	125	4	775
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO OBSCN ARHGEF11 ARHGEF15 FARP1	9.30e-05	66	125	5	722
GeneFamily	Immunoglobulin lambda locus at 22q11.2	IGLC7 IGLC1 IGLC2 IGLC3 IGLC6	3.81e-04	89	125	5	353
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	PDCD1 LILRB3 LILRA6 NRP1 TFRC FCGR2C CD19 FCGR2B NECTIN2 TNFRSF1A	4.13e-04	394	125	10	471
GeneFamily	AF4/FMR2 family\|Super elongation complex	MLLT1 AFF1	1.65e-03	9	125	2	1280
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DOCK1 NCOA2 MAP2K4 SUPT20H TRIO USP24 PEX14 TAB2 MED1 NCOR2 ASAP2 KLF10 WDHD1 ATXN2 TJP2 AFF1 ROCK1 ZFHX3 MICAL3 MTCL1 SPEN	5.86e-07	856	182	21	M4500
Coexpression	TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL	LILRB3 PDLIM7 OTUD1 LILRA6 KDM6B LCP2 TFRC HIVEP3 NCOR2 OSM KLF10 TLE3 NECTIN2 C1orf122 ROCK1 MAML2 TNFRSF1A	1.30e-05	724	182	17	M41700
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Naive_B_cells\|bone_marrow / Manually curated celltypes from each tissue	PRICKLE1 SNX29 IGLC7 CD19 FCGR2B IGLC1 MICAL3 IGLC2 IGLC3 IGLC6	6.48e-09	190	182	10	3d45d5011305f13634013d9eeb98f235517dd54e
ToppCell	nucseq-Immune-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SIPA1L3 SNX29 CD19 EHMT1 IGLC1 MICAL3 IGLC2 IGLC3 RUBCN	7.07e-08	184	182	9	911658e7bb499c1bbc8419eec8ff88729bc39a75
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SIPA1L3 SNX29 CD19 EHMT1 IGLC1 MICAL3 IGLC2 IGLC3 RUBCN	7.07e-08	184	182	9	942b58ae7172bb5f97e55b032db9329d161854af
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B-Naive_B_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	PRICKLE1 OTUD1 SNX29 CD19 FCGR2B IGLC1 MICAL3 IGLC2 IGLC3	1.06e-07	193	182	9	eb497d62a45ad77b2578b03a84cb3edc83207be5
ToppCell	Sigmoid-(6)_Macrophage-(61)_LYVE1_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	DOCK1 LILRB3 CEBPD RAPH1 LILRA6 NRP1 ASAP2 FCGR2B ZFHX3	1.44e-07	200	182	9	bc0280d52e4edc2c5edf4ead164a1c7cf3fccd60
ToppCell	Sigmoid-Macrophage-LYVE1_Macrophage\|Sigmoid / Region, Cell class and subclass	DOCK1 LILRB3 CEBPD RAPH1 LILRA6 NRP1 ASAP2 FCGR2B ZFHX3	1.44e-07	200	182	9	851a1b372ddbec522829069e69ed36a1f4832131
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRIO SLC38A5 LARP1B CD19 IGLC2 IGLC3 IGLC6 MTCL1	7.29e-07	178	182	8	6765c6970b1f2b719a20d2afd7471e1c262f3fc4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRIO SLC38A5 LARP1B CD19 IGLC2 IGLC3 IGLC6 MTCL1	7.29e-07	178	182	8	693f1135d9c5545945e80c7ba3d098afc0ccac29
ToppCell	10x5'-GI_small-bowel-Lymphocytic_B-Naive_B_cells\|GI_small-bowel / Manually curated celltypes from each tissue	PRICKLE1 SNX29 IGLC7 CD19 FCGR2B IGLC2 IGLC3 IGLC6	8.99e-07	183	182	8	be294d22b91dbcf1e8d22e6a31c39b5caaad4751
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 PCLO OBSCN ADGRV1 PTPRQ KCNQ2 MYO15A ST18	9.36e-07	184	182	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 PCLO OBSCN ADGRV1 PTPRQ KCNQ2 MYO15A ST18	9.36e-07	184	182	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 PCLO OBSCN ADGRV1 PTPRQ KCNQ2 MYO15A ST18	9.36e-07	184	182	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	IIF-Lymphocyte-B-B_naive\|IIF / Disease, Lineage and Cell Type	SNX29 IGLC7 CD19 FCGR2B MICAL3 IGLC2 IGLC3 IGLC6	9.75e-07	185	182	8	dec48908addfc71f32f5ce0ce73f2926e476f60b
ToppCell	IIF-Lymphocyte-B\|IIF / Disease, Lineage and Cell Type	SNX29 IGLC7 CD19 FCGR2B MICAL3 IGLC2 IGLC3 IGLC6	1.06e-06	187	182	8	bba950ad8f4cd9be416516043724fc22786d879e
ToppCell	Control-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	TRIO SIPA1L3 SNX29 CD19 EHMT1 MICAL3 IGLC2 IGLC3	1.06e-06	187	182	8	4e64be635f445276e71f2937f33f041c3a4204ab
ToppCell	Multiple_Sclerosis-Lymphocyte-B-B_naive\|Multiple_Sclerosis / Disease, Lineage and Cell Type	SNX29 IGLC7 CD19 FCGR2B MICAL3 IGLC2 IGLC3 IGLC6	1.10e-06	188	182	8	19b7f92ca46c15b2ac7bba8827eeb85496cdc5f0
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PAG1 PRICKLE1 PDLIM7 SPEG DACT1 SEMA6D ZFHX3 MTCL1	1.10e-06	188	182	8	3004e961d214919e08c7cd5f10c3de5cf85b35a3
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CTTNBP2 CEBPD OBSCN GDNF DACT1 FARP1 CACNA1G MAML2	1.10e-06	188	182	8	997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCell	Adult\|World / Lineage, Cell type, age group and donor	SIPA1L3 LCP2 SNX29 TFRC NCOR2 OSM PRKAG2 ALOX15B	1.15e-06	189	182	8	5cd285bfad973125d46d704fec18b21266a63379
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FKBP15 LILRB3 CEBPD LCP2 PRAM1 KLF10 TLE3 TNFRSF1A	1.62e-06	198	182	8	c26c909e95225440abdf558b1b858ffc06177000
ToppCell	COVID-19-COVID-19_Convalescent-Lymphocyte-B-B_naive\|COVID-19_Convalescent / Disease, condition lineage and cell class	SIPA1L3 SNX29 IGLC7 CD19 FCGR2B MICAL3 IGLC2 IGLC3	1.75e-06	200	182	8	5c1b51b9571681d8b792d1443d9f8926dcd55b29
ToppCell	mild_COVID-19-HSPC\|mild_COVID-19 / disease group, cell group and cell class (v2)	ZNF704 HSPG2 MAP7 TFR2 SGK2 TRIM9 DCBLD2	6.03e-06	168	182	7	90b33962adb77d8326dee403712118398b4d1315
ToppCell	metastatic_Brain-B_lymphocytes-Plasma_cells\|metastatic_Brain / Location, Cell class and cell subclass	SLC38A5 IGLC7 CD19 FCGR2B IGLC2 IGLC3 IGLC6	6.51e-06	170	182	7	53634da9e9c72f6400639954c286c6e38ea5a188
ToppCell	ICU-SEP-Lymphocyte-B-B_intermediate\|ICU-SEP / Disease, Lineage and Cell Type	PCLO CD19 FCGR2B IGLC2 IGLC3 IGLC6 PROX1	6.77e-06	171	182	7	2e44bf6f3d90193e7cadcac48bb852bd632a81bc
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pre-B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SNX29 IGLC7 CD19 FCGR2B IGLC2 IGLC3 IGLC6	7.30e-06	173	182	7	67c342295b8a06ce38e081ba74478c568917a396
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF704 GRM6 TFR2 OSM MTCL1 ALOX15B PDZD4	7.30e-06	173	182	7	3612772632ddf11eb48579cae9a8ccab6b3f1f52
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF704 GRM6 TFR2 OSM MTCL1 ALOX15B PDZD4	7.30e-06	173	182	7	4dc261ebcdb9bdcfca1451da1bd254f0dc5de203
ToppCell	Adult-Mesenchymal-pericyte_cell-D175\|Adult / Lineage, Cell type, age group and donor	PAG1 OBSCN SGK2 EBF2 SEMA6D NEURL1B RCAN2	7.30e-06	173	182	7	fd6653d6be9ca6ac36798590694efe03cb758c67
ToppCell	IIF-Lymphocyte-B-B_intermediate\|IIF / Disease, Lineage and Cell Type	SIPA1L3 CD19 FCGR2B IGLC2 IGLC3 IGLC6 MTCL1	7.87e-06	175	182	7	327f8ee3669c3fc5ba50abc3b4f3e068637fd8d8
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRIO SIPA1L3 SNX29 CD19 FCGR2B IGLC2 IGLC3	8.48e-06	177	182	7	37d1abe1a9d8f2b8f4d146bbf1db94104eab6593
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PAG1 LILRA6 LCP2 NEDD9 PRAM1 OSM FCGR2B	9.81e-06	181	182	7	8657d35cd3dff6c89d0fde67d7e7e81e1d6c8884
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-1\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SNX29 CD19 FCGR2B MICAL3 IGLC2 IGLC3 MTCL1	9.81e-06	181	182	7	6df40f86c569b6ecfc3137a68d1355b012dbf6bf
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PAG1 PRICKLE1 PDLIM7 SEMA6D ZFHX3 MTCL1 PRKAG2	1.05e-05	183	182	7	e84539978ab4de42e19186aed00f24bb50cbc21f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZNF704 PPP1R13B ADGRV1 RHPN1 MTUS1 FARP1 KCNQ2	1.09e-05	184	182	7	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC38A5 IGLC7 EHMT1 IGLC2 IGLC3 IGLC6 PIF1	1.17e-05	186	182	7	b9fb7210f615faff0633a1c82dd3be38cb72a00b
ToppCell	Control-Lymphoid-B_Plasma\|Lymphoid / Disease state, Lineage and Cell class	TRIO OTUD1 IGLC7 EHMT1 IGLC2 IGLC3 IGLC6	1.17e-05	186	182	7	a08a50bff4e629588faa22440d57334b1df0e8df
ToppCell	COVID-19_Convalescent-Lymphoid_B-B_naive\|COVID-19_Convalescent / Disease group, lineage and cell class	SNX29 IGLC7 CD19 FCGR2B MICAL3 IGLC2 IGLC3	1.17e-05	186	182	7	9d339f57036d17572882ebb801f2be9b1d1ddc1c
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SIPA1L3 SNX29 CD19 FCGR2B MICAL3 IGLC2 IGLC3	1.21e-05	187	182	7	d01926be1c8846a25fb6706e26b56b808b69f8f0
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PAG1 PDLIM7 SPEG DACT1 SEMA6D ZFHX3 MTCL1	1.21e-05	187	182	7	387cb27c8a20031cd87381a9e1172f1f62e1488b
ToppCell	IPF-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	TRIO SIPA1L3 SNX29 CD19 MICAL3 IGLC2 IGLC3	1.21e-05	187	182	7	af1327559f7e01bec070881cae52834917c3da65
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CTTNBP2 TRIO SIPA1L3 SNX29 NEDD9 FARP1 MAML2	1.25e-05	188	182	7	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	HSPG2 CTTNBP2 PRR36 PACRG WNK3 MUC20 PROX1	1.25e-05	188	182	7	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PAG1 PDLIM7 SPEG SEMA6D ZFHX3 MTCL1 PRKAG2	1.30e-05	189	182	7	b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK1 NCOA2 ARID1B SEMA6D FARP1 MAML2 PROX1	1.30e-05	189	182	7	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	Multiple_Sclerosis-Lymphocyte-B\|Multiple_Sclerosis / Disease, Lineage and Cell Type	SNX29 IGLC7 CD19 FCGR2B IGLC2 IGLC3 IGLC6	1.30e-05	189	182	7	864f666b1e8557a689320075036920e3ac589b8b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SNX29 ARID1B CD19 AFF1 MICAL3 IGLC2 IGLC3	1.34e-05	190	182	7	0724665ac8238f2383c3a929d89abf4a48ec2420
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	TRIO SIPA1L3 CD19 MICAL3 IGLC2 IGLC3 RUBCN	1.34e-05	190	182	7	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	NS-critical-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ZNF704 CEP85 TCF19 RAPH1 ASAP2 NEURL1B PYGO1	1.34e-05	190	182	7	7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ZNF704 CEP85 TCF19 ARHGEF11 ASAP2 NEURL1B PYGO1	1.34e-05	190	182	7	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	Healthy/Control-B_intermediate\|World / Disease group and Cell class	IGLC7 CD19 FCGR2B MICAL3 IGLC2 IGLC3 IGLC6	1.44e-05	192	182	7	2266aa695955f5d885708e6bc0d5a8827c306223
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-13\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SNX29 CD19 FCGR2B MICAL3 IGLC2 IGLC3 IGLC6	1.44e-05	192	182	7	e5ab932b4c2fed538161281ae07dfcdd82706fdd
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SNX29 IGLC7 CD19 FCGR2B MICAL3 IGLC2 IGLC3	1.44e-05	192	182	7	ee309564ac6136c1dc314d5cd3603687ee2266f2
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PAG1 PDLIM7 SPEG SEMA6D MTUS1 ZFHX3 MTCL1	1.49e-05	193	182	7	000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6
ToppCell	PCW_13-14-Epithelial-Epithelial_neuroendo\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	VWA5B2 PCLO ADGRV1 MAP7 SLC7A4 ST18 PROX1	1.49e-05	193	182	7	8603d1a38955ad2529d04e4704467c73ea5bfbda
ToppCell	COVID-19_Convalescent-Lymphoid_B\|COVID-19_Convalescent / Disease group, lineage and cell class	SNX29 IGLC7 CD19 FCGR2B MICAL3 IGLC2 IGLC3	1.49e-05	193	182	7	e0973f3f3ae8ddcb6e22af5eb1e0fe6fe607a20b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	KDM6B SNX29 CD19 MICAL3 IGLC2 IGLC3 RUBCN	1.54e-05	194	182	7	5cd72330c9d9bb21b6c9d5d35085eade101486d1
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FAT4 PRICKLE1 ARHGEF15 NRP1 SEMA6D FCGR2B	1.54e-05	194	182	7	c8b9551b93a5aed62154b487db90130604a6125c
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGLC7 CD19 FCGR2B IGLC2 IGLC3 IGLC6 RUBCN	1.59e-05	195	182	7	2d18f08f33f3b261c77b8adf87d1a184cc6d7400
ToppCell	11.5-Distal-Mesenchymal-Airway_Smooth_Muscle\|Distal / Age, Tissue, Lineage and Cell class	PAG1 PDLIM7 SPEG DACT1 SEMA6D ZFHX3 MTCL1	1.64e-05	196	182	7	05530fe7a5681c2f39b95016cd22ef99d6ac0430
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 NCOA2 SIPA1L3 ADGRV1 HIVEP3 ARID1B MAML2	1.64e-05	196	182	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	3'_v3-Lung-Myeloid_Mac-Intermediate_macrophages\|Lung / Manually curated celltypes from each tissue	CEBPD RAPH1 PDLIM7 NRP1 FCGR2B TLE3 C1orf122	1.70e-05	197	182	7	bcb4dc17dae705bd84ea6a2842d6b107562baeb7
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 NCOA2 TRIO SIPA1L3 ADGRV1 ARID1B MAML2	1.75e-05	198	182	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 NCOA2 TRIO SIPA1L3 ARID1B AFF1 MAML2	1.81e-05	199	182	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	11.5-Airway-Mesenchymal-Airway_Smooth_Muscle\|Airway / Age, Tissue, Lineage and Cell class	PAG1 PDLIM7 SPEG DACT1 SEMA6D ZFHX3 MTCL1	1.81e-05	199	182	7	1a8c77d241bd817a195e1532fd25f51358cb1ff1
ToppCell	(2)_B_cell\|World / shred on Cell_type and subtype	SLC38A5 IGLC7 CD19 FCGR2B EHMT1 IGLC2 IGLC3	1.81e-05	199	182	7	751cfdbc873390bd03837a57367a290f34d53f38
ToppCell	MS-IIF-Lymphocyte-B-B_naive\|IIF / Disease, condition lineage and cell class	SNX29 IGLC7 CD19 FCGR2B MICAL3 IGLC2 IGLC3	1.87e-05	200	182	7	15f429137b2a3906724118085fcd59750cd767c7
ToppCell	control-Neutrophil\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LILRB3 CEBPD LILRA6 ARHGEF11 PRAM1 TNRC18 KLF10	1.87e-05	200	182	7	b5d197472799cc61d7497faed91ac2564ae4930a
ToppCell	MS-IIF-Lymphocyte-B\|IIF / Disease, condition lineage and cell class	SNX29 IGLC7 CD19 FCGR2B MICAL3 IGLC2 IGLC3	1.87e-05	200	182	7	a0f3362b7ddfc122e30e75fb541bb0b7d0321c72
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-B-B_naive\|Multiple_Sclerosis / Disease, condition lineage and cell class	SNX29 IGLC7 CD19 FCGR2B MICAL3 IGLC2 IGLC3	1.87e-05	200	182	7	4d16545608aa4289a5e406512100c617ccee6a97
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-B\|COVID-19_Mild / Disease, condition lineage and cell class	SIPA1L3 SNX29 CD19 FCGR2B MICAL3 IGLC2 IGLC3	1.87e-05	200	182	7	11b51dfca161342d92126e0a83d10864348ba3ef
ToppCell	facs-Lung-Endomucin-24m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRFN1 PPP1R13B LARP1B SLC7A4 WDHD1 NEURL1B	2.62e-05	142	182	6	0a87c0d74e281da5dc4f59e09a5e99c62b1ea801
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_3\|390C / Donor, Lineage, Cell class and subclass (all cells)	LILRB3 OTUD1 PRAM1 FCGR2B CACNA1G ST18	3.84e-05	152	182	6	f717aae4882e9b67e5e40f4ef5b0d35f74a89165
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	OTUD1 KDM6B OSM KLF10 FCGR2B PROX1	4.28e-05	155	182	6	c4dc0fa1d0e657753a56939eb4829fb60382c17f
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LILRB3 CEBPD F12 PRAM1 MTUS1 KCNQ2	4.60e-05	157	182	6	d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PAG1 PDLIM7 DACT1 SEMA6D ZFHX3 MTCL1	4.60e-05	157	182	6	b9d04ee417c0d8ea0801d10f1c54e138587009fd
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LILRB3 CEBPD F12 PRAM1 MTUS1 KCNQ2	4.60e-05	157	182	6	0673c7161c25feceee8f1e5fd237171576c42c6b
ToppCell	356C-Fibroblasts-Fibroblast-D\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	LILRB3 PCLO DENND1C ARHGEF15 FCGR2B PROX1	4.93e-05	159	182	6	0a3a363b30a8c741e1a3e2525725108d03c21776
ToppCell	356C-Fibroblasts-Fibroblast-D-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	LILRB3 PCLO DENND1C ARHGEF15 FCGR2B PROX1	4.93e-05	159	182	6	299e2162a82e31196d7f3a110c2db622349edfff
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-naive_B_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RPF1 IGLC7 FBXO31 IGLC2 IGLC3 IGLC6	5.11e-05	160	182	6	bfbac5ed3273b4430314c6c25cdc1bf0c42b27a1
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	RAPH1 OBSCN RHPN1 ARID1B FARP1 MICAL3	5.29e-05	161	182	6	58381131e651744b5141b202f9d6063f55432db5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRIO CD19 FCGR2B IGLC2 IGLC3 ALOX15B	5.29e-05	161	182	6	63f0b97c741b610c450f65fa5764d712bfe09ce8
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PDCD1 LILRB3 LILRA6 LCP2 OSM ST18	5.47e-05	162	182	6	2b47fd256490d0c2d9ad5950aa26410aeb6ec995
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage_3\|343B / Donor, Lineage, Cell class and subclass (all cells)	OTUD1 KDM6B PRAM1 KLF10 FCGR2B CACNA1G	5.47e-05	162	182	6	0acb8f7b51bf422d4f4f8e99bd10360163ae4eb7
ToppCell	10x5'-blood-Lymphocytic_B-ABC_aged-B_memory\|blood / Manually curated celltypes from each tissue	CD19 FCGR2B IGLC1 IGLC2 IGLC3 XKR5	5.86e-05	164	182	6	0424b23fc540580e7c15c50a7a03dff7c25014fa
ToppCell	356C-Myeloid-Mast_cell-\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ZNF704 TFR2 SEMA6D MTCL1 CREB3L3 WNK3	5.86e-05	164	182	6	f7288ec4daf494dae770ea6c58bead27660ccae1
ToppCell	356C-Myeloid-Mast_cell\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ZNF704 TFR2 SEMA6D MTCL1 CREB3L3 WNK3	5.86e-05	164	182	6	b3192c443f4848e6a8afdb89c155f9ec42a154b0
ToppCell	10x5'-bone_marrow-Lymphocytic_B_plasma-Plasmablasts\|bone_marrow / Manually curated celltypes from each tissue	SLC38A5 IGLC7 IGLC1 IGLC2 IGLC3 IGLC6	5.86e-05	164	182	6	67260e9f569f0acaeb0e65f69cde230f91cd3d26
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 ADGRV1 MAP7 RHPN1 GRID2IP ST18	6.06e-05	165	182	6	4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TFR2 WDHD1 TRIM9 PTPRQ SPEN ALOX15B	6.26e-05	166	182	6	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TFR2 WDHD1 TRIM9 PTPRQ SPEN ALOX15B	6.26e-05	166	182	6	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOA2 LILRB3 PDE3B FCGR2B CACNA1G RUBCN	6.48e-05	167	182	6	f5bffa77061baec0ba87bd688a047595f32534db
ToppCell	droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRR22 GRM6 OSM ALOX15B PDZD4 MUC20	6.69e-05	168	182	6	0e99ecd94ab8e5372e30433d7d0aa76b4d54257a
ToppCell	droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRR22 GRM6 OSM ALOX15B PDZD4 MUC20	6.69e-05	168	182	6	34722e14f28313f2e4644b3c1861ef12958cee9f
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive\|lymph-node_spleen / Manually curated celltypes from each tissue	HIVEP3 CD19 IGLC1 MICAL3 IGLC2 IGLC3	6.69e-05	168	182	6	494d5a11154ff22fedb25f4036d730cef376da60
ToppCell	IIH-naiveBc\|IIH / Condition, Cell_class and T cell subcluster	TRIO IGLC7 CD19 IGLC2 IGLC3 XKR5	6.69e-05	168	182	6	8450ed6720d308c711dfbc76652e5821be7b8e93
ToppCell	IIH-naiveBc-\|IIH / Condition, Cell_class and T cell subcluster	TRIO IGLC7 CD19 IGLC2 IGLC3 XKR5	6.69e-05	168	182	6	27b500f79aedc4669988670c92ff1a47dcbdf2a0
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3B LCP2 PRAM1 OSM FCGR2B ST18	6.92e-05	169	182	6	b2fdf9f842dc7c181bc951a8a6932c916ed835ef
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3B LCP2 PRAM1 OSM FCGR2B ST18	6.92e-05	169	182	6	2322f03a115c662f808ebfc892192b7d38d48181
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SLC38A5 ADGRV1 HIVEP3 DACT1 ADGRG2 TLE3	7.15e-05	170	182	6	ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCell	mild_COVID-19-HSPC\|World / disease group, cell group and cell class (v2)	ZNF704 HSPG2 MAP7 SGK2 TRIM9 DCBLD2	7.15e-05	170	182	6	85c476e0bc496445e868a88849960598d97bdea2
Computational	Genes upregulated in subsets of cells of a given type within various tumors	IGLC7 IGLC1 IGLC2 IGLC3 IGLC6	1.10e-04	49	105	5	GAVISH_3CA_MALIGNANT_METAPROGRAM_36_IG
Drug	Vigabatrin [60643-86-9]; Up 200; 31uM; MCF7; HT_HG-U133A	PDE3B TRIO PDLIM7 PCLO SIPA1L3 SOX30 WNK1 NRP1 SGK2 GSPT2 EHMT1	4.76e-07	199	177	11	5415_UP
Drug	6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine	VWA5B2 RAPH1 PRR36 APC2 KDM6B PRR12 ZFHX3 SPEN	1.55e-06	104	177	8	ctd:C000595015
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; PC3; HT_HG-U133A	NCOA2 CEP85 SIPA1L3 PARP3 TAB2 CC2D1A TSC2 KDM6B NRP1 MTUS1	3.14e-06	195	177	10	4644_DN
Disease	red blood cell density measurement	ZNF704 ZNF219 RPS6KB1 ADGRV1 KDM6B ARHGEF11 WNK1 TFR2 TFRC FCGR2C ARID1B FCGR2B ATXN2 TLE3 TJP2 AFF1 MAML2 PRKAG2 MYO15A PROX1	3.42e-07	880	176	20	EFO_0007978
Disease	total blood protein measurement	NCOA2 PAG1 SLC38A5 TAB2 C4orf17 NCOR2 EPS15L1 KMT2D FCGR2B ATXN2 TLE3 ROCK1 MICAL3 MAML2	5.74e-07	449	176	14	EFO_0004536
Disease	systemic lupus erythematosus (implicated_via_orthology)	PDCD1 RC3H1 FCGR2C FCGR2B RUBCN	5.71e-06	43	176	5	DOID:9074 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	NCOA2 MAP2K4 RAPH1 PDLIM7 RPS6KB2 APC2 OBSCN GRM6 WNK1 CIC TFRC ARID1B KMT2D FARP1 TLE3 NECTIN2 EHMT1 AFF1 SPEN PDZD4	7.06e-06	1074	176	20	C0006142
Disease	lung non-small cell carcinoma (is_implicated_in)	NCOA2 MAP2K4 NRP1 ARID1B KMT2D ZFHX3 TNFRSF1A	2.10e-05	139	176	7	DOID:3908 (is_implicated_in)
Disease	CHROMOSOME 6q24-q25 DELETION SYNDROME	TAB2 ARID1B	3.54e-05	2	176	2	C3150215
Disease	hematocrit	SLAIN2 RAPH1 PPP1R13B ADGRV1 USP37 ARHGEF15 TFR2 MRPS18A PRR12 NCOR2 FCGR2C ARID1B FCGR2B ATXN2 AFF1 MAML2 PRKAG2 PROX1	3.75e-05	1011	176	18	EFO_0004348
Disease	Spinocerebellar Ataxia Type 2	CIC ATXN2 CACNA1G RUBCN	4.93e-05	34	176	4	C0752121
Disease	Spinocerebellar Ataxia Type 1	CIC ATXN2 CACNA1G RUBCN	4.93e-05	34	176	4	C0752120
Disease	Spinocerebellar Ataxia Type 5	CIC ATXN2 CACNA1G RUBCN	4.93e-05	34	176	4	C0752123
Disease	Spinocerebellar Ataxia Type 7	CIC ATXN2 CACNA1G RUBCN	4.93e-05	34	176	4	C0752125
Disease	Spinocerebellar Ataxia Type 6 (disorder)	CIC ATXN2 CACNA1G RUBCN	4.93e-05	34	176	4	C0752124
Disease	Ataxia, Spinocerebellar	CIC ATXN2 CACNA1G RUBCN	4.93e-05	34	176	4	C0087012
Disease	Spinocerebellar Ataxia Type 4	CIC ATXN2 CACNA1G RUBCN	5.54e-05	35	176	4	C0752122
Disease	alcohol consumption measurement	DOCK1 NCOA2 TOB2 CTTNBP2 RAPH1 PCLO PPP1R13B OTOL1 ADGRV1 MED1 C4orf17 DACT1 NCOR2 SEMA6D FARP1 ZFHX3 MICAL3 MYO15A MGA ST18	5.58e-05	1242	176	20	EFO_0007878
Disease	basophil percentage of leukocytes	NCOA2 CEBPD C7orf57 PRAM1 FCGR2C P2RY2 FCGR2B AFF1	1.12e-04	243	176	8	EFO_0007992
Disease	FEV/FEC ratio	HSPG2 MAP2K4 CTTNBP2 CES5A SPEG SOX30 FAM83H HIVEP3 PRR12 FCGR2C ASAP2 MTUS1 FCGR2B ZFHX3 MICAL3 MTCL1 MAML2 MYO15A MGA	1.45e-04	1228	176	19	EFO_0004713
Disease	cystatin C measurement	RPS6KB1 OTUD1 ADGRV1 USP37 F12 EBF2 ATXN2 NECTIN2 PRKAG2 RCAN2	1.61e-04	402	176	10	EFO_0004617
Disease	Diffuse Large B-Cell Lymphoma	RPS6KB1 KMT2D NECTIN2 SPEN	3.29e-04	55	176	4	C0079744
Disease	viral infectious disease (implicated_via_orthology)	PTPRQ EHMT1	3.50e-04	5	176	2	DOID:934 (implicated_via_orthology)
Disease	monocyte count	PAG1 LILRB3 CEBPD LILRA6 DENND1C ADGRV1 WNK1 CIC SGK2 HIVEP3 NCOR2 FCGR2C P2RY2 FCGR2B ATXN2 MLLT1 NEURL1B TNFRSF1A PARP12	3.59e-04	1320	176	19	EFO_0005091
Disease	pseudohypoaldosteronism (implicated_via_orthology)	WNK1 WNK3	5.22e-04	6	176	2	DOID:4479 (implicated_via_orthology)
Disease	leukocyte immunoglobulin-like receptor subfamily B member 3 measurement	LILRB3 LILRA6	5.22e-04	6	176	2	EFO_0802705
Disease	leukocyte immunoglobulin-like receptor subfamily A member 6 measurement	LILRB3 LILRA6	5.22e-04	6	176	2	EFO_0801767
Disease	Leukemia, Myelocytic, Acute	CEBPD TRIO TSC2 FANCM NECTIN2 SLX4	6.20e-04	173	176	6	C0023467
Disease	testosterone measurement	ZNF704 ZNF219 KDM6B ARHGEF15 EBF2 NEDD9 DACT1 NCOR2 ARID1B TTBK1 SEMA6D P2RY2 AFF1 ZFHX3 YY1AP1 MYO15A FKBP4 PROX1	6.46e-04	1275	176	18	EFO_0004908
Disease	breast carcinoma (is_marker_for)	KDM6B KMT2D MTUS1 ZFHX3	6.61e-04	66	176	4	DOID:3459 (is_marker_for)
Disease	suicidal ideation	NCOA2 OSM ZFHX3	6.80e-04	29	176	3	EFO_0004320
Disease	multiple sclerosis	NCOA2 PRICKLE1 RPS6KB1 GDNF NCOR2 EPS15L1 ASAP2 ATXN2 AFF1 ZFHX3 TNFRSF1A	9.26e-04	594	176	11	MONDO_0005301
Disease	zinc-alpha-2-glycoprotein measurement	NPHS2 IGLC7	9.67e-04	8	176	2	EFO_0802228
Disease	kidney disease (is_marker_for)	ARID1B TNFRSF1A	9.67e-04	8	176	2	DOID:557 (is_marker_for)
Disease	tumor necrosis factor receptor II measurement	NPHS2 ATXN2	9.67e-04	8	176	2	EFO_0008384
Disease	malaria (implicated_via_orthology)	FCGR2C FCGR2B	1.24e-03	9	176	2	DOID:12365 (implicated_via_orthology)
Disease	plexin-B2 measurement	FCGR2C FCGR2B	1.24e-03	9	176	2	EFO_0021867
Disease	alcohol dependence (implicated_via_orthology)	RPS6KB1 RPS6KB2	1.24e-03	9	176	2	DOID:0050741 (implicated_via_orthology)
Disease	dilated cardiomyopathy (implicated_via_orthology)	PDCD1 FLNC MED1 PROX1	1.36e-03	80	176	4	DOID:12930 (implicated_via_orthology)
Disease	tongue squamous cell carcinoma (is_marker_for)	MAP2K4 FANCM MTUS1	1.40e-03	37	176	3	DOID:0050865 (is_marker_for)
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	USP24 TFR2 ATXN2 NECTIN2 SNRPC	1.41e-03	137	176	5	EFO_0004611, EFO_0008591
Disease	monocyte measurement	RPS6KB1 P2RY2 ATXN2 AFF1	1.49e-03	82	176	4	EFO_0803547
Disease	serum non-albumin protein measurement	RPS6KB1 TAB2 NCOR2 FCGR2C FCGR2B ATXN2 TLE3 AFF1	1.52e-03	361	176	8	EFO_0004568
Disease	monocyte percentage of leukocytes	PAG1 CEBPD KDM6B ARHGEF11 WNK1 SNX29 EPS15L1 P2RY2 FCGR2B ATXN2 TLE3 MLLT1	1.53e-03	731	176	12	EFO_0007989
Disease	response to glucocorticoid, osteonecrosis	ZNF704 PAG1 ZFHX3	1.63e-03	39	176	3	EFO_0004259, GO_0051384
Disease	platelet crit	NCOA2 CEP85 ADGRV1 KDM6B ARHGEF11 TFR2 MRPS18A P2RY2 ATXN2 NECTIN2 AFF1 TNFRSF1A PIF1 RCAN2	1.78e-03	952	176	14	EFO_0007985
Disease	apolipoprotein A 1 measurement	NCOA2 COX19 PDE3B GDNF NRP1 NCOR2 FCGR2B ATXN2 NECTIN2 AFF1 CREB3L3 MGA FKBP4	1.80e-03	848	176	13	EFO_0004614
Disease	eosinophil percentage of leukocytes	PDCD1 CEP85 CEBPD KDM6B LCP2 WNK1 HIVEP3 EPS15L1 ATXN2 TLE3 NEURL1B SNRPC	1.81e-03	746	176	12	EFO_0007991
Disease	Systemic lupus erythematosus	PDCD1 FCGR2B	1.88e-03	11	176	2	cv:C0024141
Disease	neuroticism measurement, cognitive function measurement	CTTNBP2 PCLO SNX29 NRP1 NEDD9 TTBK1 SEMA6D FARP1 ZFHX3 PROX1	2.21e-03	566	176	10	EFO_0007660, EFO_0008354
Disease	Cooley's anemia	TFR2 TFRC	2.24e-03	12	176	2	C0002875
Disease	Thalassemia Intermedia	TFR2 TFRC	2.24e-03	12	176	2	C0271979
Disease	Thalassemia Minor	TFR2 TFRC	2.24e-03	12	176	2	C0085578
Disease	oncostatin-M measurement	IGLC7 P2RY2	2.24e-03	12	176	2	EFO_0010792
Disease	beta Thalassemia	TFR2 TFRC	2.24e-03	12	176	2	C0005283
Disease	hepatocellular carcinoma (is_marker_for)	PDCD1 MAP2K4 SOX30 TSC2 NRP1 ZFHX3 NKX3-1	2.28e-03	301	176	7	DOID:684 (is_marker_for)
Disease	left ventricular systolic function measurement	FLNC OBSCN ATXN2	2.31e-03	44	176	3	EFO_0008206
Disease	Neurodevelopmental Disorders	TRIO HIVEP3 ARID1B KCNQ2	2.36e-03	93	176	4	C1535926
Disease	Multiple Sclerosis	PDCD1 NECTIN2 TNFRSF1A	2.46e-03	45	176	3	C0026769
Disease	Multiple Sclerosis, Acute Fulminating	PDCD1 NECTIN2 TNFRSF1A	2.46e-03	45	176	3	C0751324
Disease	bipolar disorder	SLAIN2 PDE3B PCLO PPP1R13B ARHGEF15 CDAN1 ASAP2 KMT2D TLE3 KIF5B	2.54e-03	577	176	10	MONDO_0004985
Disease	colon carcinoma (is_marker_for)	KMT2D TNFRSF1A	2.64e-03	13	176	2	DOID:1520 (is_marker_for)
Disease	prostate carcinoma	RPF1 TRIO SIPA1L3 PPP1R13B PEX14 GDNF MRPS18A EBF2 NEDD9 ZFHX3 NKX3-1 SPEN WNK3	2.77e-03	891	176	13	EFO_0001663
Disease	cortical thickness	VWA5B2 NCOA2 HSPG2 CTTNBP2 ADGRV1 NRP1 DACT1 ARID1B ATXN2 AFF1 MICAL3 KIF5B MTCL1 PRKAG2 ST18	2.85e-03	1113	176	15	EFO_0004840
Disease	iron biomarker measurement, transferrin saturation measurement	TFR2 TFRC	3.07e-03	14	176	2	EFO_0004461, EFO_0006333
Disease	5-methyluridine (ribothymidine) measurement	PCLO C7orf57	3.07e-03	14	176	2	EFO_0020013
Disease	alkaline phosphatase measurement	NCOA2 HSPG2 COX19 MAP2K4 TSC2 LARP1B TULP2 HIVEP3 FCGR2C FCGR2B ATXN2 NECTIN2 MICAL3 DCBLD2	3.18e-03	1015	176	14	EFO_0004533
Disease	serum gamma-glutamyl transferase measurement	COX19 SIPA1L3 ARHGEF11 ARHGEF15 NCOR2 FCGR2C SEMA6D FCGR2B NECTIN2 AFF1 YY1AP1 MICAL3 PROX1	3.43e-03	914	176	13	EFO_0004532
Disease	Hemoglobin F Disease	TFR2 TFRC	3.53e-03	15	176	2	C0019025
Disease	phospholipids in IDL measurement	COX19 ATXN2 NECTIN2	3.72e-03	52	176	3	EFO_0022164
Disease	substance-related disorder	TOB2 PPP1R13B SEMA6D	3.72e-03	52	176	3	MONDO_0002494
Disease	blood phosphate measurement	HSPG2 RPS6KB1 F12 ATXN2 ZFHX3	3.98e-03	174	176	5	EFO_0010972
Disease	ureidopropionic acid measurement	ZNF704 PAG1	4.02e-03	16	176	2	EFO_0010542
Disease	transferrin saturation measurement	TFR2 TFRC	4.02e-03	16	176	2	EFO_0006333
Disease	T-Cell Lymphoma	KMT2D MGA	4.02e-03	16	176	2	C0079772
Disease	Metastatic melanoma	MAP2K4 TRIO TTBK1	4.14e-03	54	176	3	C0278883
Disease	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	WDHD1 FBXO31 MTCL1	4.14e-03	54	176	3	EFO_0000180, EFO_0003100, GO_0061479
Disease	cup-to-disc ratio measurement	FAT4 CTTNBP2 TCF19 NEDD9 OSM MTUS1 MTCL1 NEURL1B	4.44e-03	430	176	8	EFO_0006939
Disease	low affinity immunoglobulin gamma Fc region receptor II-a measurement	FCGR2C FCGR2B	4.54e-03	17	176	2	EFO_0021969
Disease	ischemia (implicated_via_orthology)	ARID1B TNFRSF1A	4.54e-03	17	176	2	DOID:326 (implicated_via_orthology)
Disease	Hypertrophic Cardiomyopathy	OBSCN KLF10 PRKAG2	4.82e-03	57	176	3	C0007194
Disease	low density lipoprotein cholesterol measurement, lipid measurement	TFR2 ATXN2 NECTIN2 SNRPC	4.91e-03	114	176	4	EFO_0004529, EFO_0004611
Disease	total cholesterol measurement, low density lipoprotein cholesterol measurement	TFR2 ATXN2 NECTIN2 SNRPC	4.91e-03	114	176	4	EFO_0004574, EFO_0004611
Disease	R-6-hydroxywarfarin measurement	ZNF704 NCOR2 SEMA6D SPEN	4.91e-03	114	176	4	EFO_0803327
Disease	Drug habituation	DOCK1 FKBP15 SEMA6D FARP1	5.06e-03	115	176	4	C0013170
Disease	Drug abuse	DOCK1 FKBP15 SEMA6D FARP1	5.06e-03	115	176	4	C0013146
Disease	Prescription Drug Abuse	DOCK1 FKBP15 SEMA6D FARP1	5.06e-03	115	176	4	C4316881
Disease	Substance-Related Disorders	DOCK1 FKBP15 SEMA6D FARP1	5.06e-03	115	176	4	C0236969
Disease	Drug Use Disorders	DOCK1 FKBP15 SEMA6D FARP1	5.06e-03	115	176	4	C0013222
Disease	Drug Dependence	DOCK1 FKBP15 SEMA6D FARP1	5.06e-03	115	176	4	C1510472
Disease	Substance Dependence	DOCK1 FKBP15 SEMA6D FARP1	5.06e-03	115	176	4	C0038580
Disease	Substance Use Disorders	DOCK1 FKBP15 SEMA6D FARP1	5.06e-03	115	176	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	DOCK1 FKBP15 SEMA6D FARP1	5.06e-03	115	176	4	C0029231
Disease	cholesterol in IDL measurement	COX19 ATXN2 NECTIN2	5.06e-03	58	176	3	EFO_0021899
Disease	Alzheimer disease, amyloid-beta measurement	ARID1B NECTIN2	5.08e-03	18	176	2	EFO_0005194, MONDO_0004975
Disease	Bone marrow hypocellularity	FANCM SLX4	5.08e-03	18	176	2	C1855710
Disease	breast cancer (is_marker_for)	TSC2 TFRC NCOR2 KMT2D ZFHX3	5.15e-03	185	176	5	DOID:1612 (is_marker_for)
Disease	Breast Carcinoma	NCOA2 MAP2K4 RPS6KB2 APC2 TFRC ARID1B KMT2D TLE3 NECTIN2	5.18e-03	538	176	9	C0678222
Disease	Substance abuse problem	DOCK1 FKBP15 SEMA6D FARP1	5.22e-03	116	176	4	C0740858
Disease	total lipids in IDL	COX19 ATXN2 NECTIN2	5.56e-03	60	176	3	EFO_0022161
Disease	platelet component distribution width	COX19 SUPT20H EWSR1 WNK1 ARHGEF15 NCOR2 MAVS P2RY2 FCGR2B ATXN2 PIF1	5.83e-03	755	176	11	EFO_0007984
Disease	free cholesterol in IDL measurement	COX19 ATXN2 NECTIN2	5.83e-03	61	176	3	EFO_0022181
Disease	blood urea nitrogen measurement	ZNF704 TOB2 PAG1 PRICKLE1 ADGRV1 ATXN2 PRKAG2 PROX1	5.95e-03	452	176	8	EFO_0004741

Protein segments in the cluster

Peptide	Gene	Start	Entry
PEPTRKFPSGPLLTS	C2orf16	31	Q68DN1
PAATAPTRPQDGNKP	EWSR1	131	Q01844
KTVFPGAVPVLPASP	EPS15L1	216	Q9UBC2
SPSKGFFSRGPQPRP	PRKAG2	71	Q9UGJ0
IPPSSAKGPVFSVPV	NEDD9	191	Q14511
LPSISPFGPNKTESP	CREB3L3	336	Q68CJ9
FLAPVAGTPAAPPKA	FCGR2B	36	P31994
NPPSFPPGDIFKSIV	FAT4	1416	Q6V0I7
RGPPFSSSQSIPVVP	ADGRG2	251	Q8IZP9
PDLKPSPQNGATFPS	ADGRV1	6226	Q8WXG9
NPTPPFTPKMGRRSI	ARHGEF11	666	O15085
AFAPVIRPQGSPSPA	EBF2	541	Q9HAK2
VSAKPGAPPQPAVSA	C1orf122	81	Q6ZSJ8
QQVPDPSGPPTFRLS	ARHGEF15	696	O94989
PFPTVGPNSVLSPQR	ARID1B	2136	Q8NFD5
VLRFQKSSPPSSPGP	SLC7A4	411	O43246
IPPPTRGNSKPLSCF	DENND1C	161	Q8IV53
SSRVLPQGPPTPAKT	CDAN1	61	Q8IWY9
SQPVPFSALGPTEKP	PPP1R13B	426	Q96KQ4
PGAAASRPLSPNKPD	ARIH2OS	51	Q8N7S6
TKIQFPGEFLTPPTP	CFAP276	106	Q5T5A4
PPFKSTARFTLNPNP	MAP2K4	51	P45985
PSRKPPALPNGIVST	RC3H1	486	Q5TC82
AKQFLISPPSSPPVG	RCAN2	106	Q14206
ASQHSGALFKPPTPP	RAPH1	676	Q70E73
PPAAGAFKERPTKPT	PACRG	56	Q96M98
EPSPGQPSTFIVPFR	HSPG2	1046	P98160
APAAPRSPNLAGKAP	MTCL1	71	Q9Y4B5
NPSLKSPPPGFDSVI	PARP3	456	Q9Y6F1
AKPIRPGQHPAASPT	KIF5B	921	P33176
TPTGDPRANASPQKP	NCOR2	946	Q9Y618
AAPAPPAAATPFKVS	OTUD1	21	Q5VV17
PAAATPFKVSLQPPG	OTUD1	26	Q5VV17
RFQPAPAKTSTPLAP	MICAL3	1281	Q7RTP6
PSRGPVSPSVSFQPL	MAVS	216	Q7Z434
PGSVKAAPAQVRPPS	MAP7	351	Q14244
GIPKQAPFRSPTAPS	NELFA	216	Q9H3P2
NTPVSPGSTFPDVKP	MGA	641	Q8IWI9
TKGPFPTSRDPLPSV	MUC20	596	Q8N307
IPLQSPRNSGSFPSP	MTUS1	1251	Q9ULD2
SPQLSLRTGPFQPPF	MYO15A	796	Q9UKN7
FLRSQGTGPKPPTPL	LRFN1	231	Q9P244
TTSAPPLPPRNVGKV	ASAP2	781	O43150
SQPSKPAPPGISQIR	ASAP2	861	O43150
FNPRSFSQPKPSTTP	ATXN2	921	Q99700
FPPRILSTRPGQKSP	KIAA1109	4881	Q2LD37
RPQSPGSSKAPLPAA	FANCM	31	Q8IYD8
QPTPPSASVPGKKAR	KDM6B	1061	O15054
SFQPRPPDKGSFPLD	COX19	11	Q49B96
SFLRGPTQPPTLPAG	GSPT2	71	Q8IYD1
FLAPVAGTPAAPPKA	FCGR2C	36	P31995
QPSPAQPRAEAPSKG	FBXO31	401	Q5XUX0
PSVSSLPAKPRPFFR	PCLO	2381	Q9Y6V0
PSPSPRPAGQFQTLV	PDCD1	156	Q15116
TGQKNFSAPPAAPPV	KCNQ2	696	O43526
KAAPPPGSPAKFRSL	PDZD4	516	Q76G19
SGSCRPKINPLTPFP	PDE3B	391	Q13370
PLGSLRFTNPQPASP	CES5A	66	Q6NT32
SPPTSIPFKSGEPAL	FKBP15	326	Q5T1M5
PGSPFKATIRPVFDP	FLNC	1141	Q14315
RTQGSLPFPSPSKPV	NPHS2	356	Q9NP85
SPRTPVSPVKFSPGD	RPS6KB1	441	P23443
TASAFPLPAGKRPPE	GDNF	16	P39905
GPRTRVQAGPFPKPT	LILRA6	16	Q6PI73
GPRTRVQAGPFPKPT	LILRB3	16	O75022
FARDAKPPTGPSPAT	P2RY2	316	P41231
SLNKTARPFGAPPPA	PDLIM7	111	Q9NR12
PKSNISVFTPPDVPG	PTPRQ	426	Q9UMZ3
ISFQTPEGAPSDPPK	PTPRQ	981	Q9UMZ3
KSSAPSRVPPLFVPQ	PARP12	236	Q9H0J9
TPSVTPALPSFPGLQ	PROSER1	796	Q86XN7
PALPSFPGLQAPSTV	PROSER1	801	Q86XN7
APFARAKSLPPSPVT	OBSCN	6801	Q5VST9
SPGPFGQEKIPSPSF	MAML2	471	Q8IZL2
KIAPPPVVSSGPFLF	NRP1	106	O14786
PPSALPTPQFGQRTT	PRICKLE1	801	Q96MT3
PAPFTRPTGTLGLNP	DERPC	461	P0CG12
PAAPAKVPSPGQQRS	APC2	1826	O95996
GQPKANPTVTLFPPS	IGLC1	1	P0CG04
KSRASPPGPSPAVTT	GRID2IP	576	A4D2P6
QGKRSVTPPPFISPT	GRM6	681	O15303
QGVPPATPPLLSTAF	DACT1	516	Q9NYF0
QTPPPVTPRAKLSFS	DOCK1	1766	Q14185
KTLSPQPHSPLGSPF	CACNA1G	1876	O43497
FKQLPSPPFLPAAGT	CEBPD	251	P49716
RRFFKVTPPPGSGPQ	CD19	331	P15391
IGASVPAFPPPSANK	CTTNBP2	366	Q8WZ74
PSPAPRRSPAGNKQA	FARP1	426	Q9Y4F1
PLGPKNPAGSRLSFP	C7orf57	186	Q8NEG2
RLSFPPVPGQKNSSP	C7orf57	196	Q8NEG2
GQPKAAPSVTLFPPS	IGLC2	1	P0DOY2
SPPRPNTQESGSAKP	C4orf17	321	Q53FE4
GSPPFQPIKSHVTIP	CEP85	76	Q6P2H3
GQPKAAPSVTLFPPS	IGLC3	1	P0DOY3
GQPKAAPSVTLFPPS	IGLC6	1	P0CF74
AQPKAPPSRTPQSGS	CC2D1A	461	Q6P1N0
PPSRTPQSGSAPTAK	CC2D1A	466	Q6P1N0
SRTQVPPVKPGIPAS	ITIH6	756	Q6UXX5
PAPGFSPSAAKVTPQ	KLF10	346	Q13118
GQPKAAPSVTLFPPS	IGLC7	1	A0M8Q6
PSTSTFKATGNQPPP	DCBLD2	696	Q96PD2
QKPPPPNSKVSGRRS	MLLT1	461	Q03111
AGSPPKIPPNATLVF	FKBP4	116	Q02790
VPGVGAPTPFSFPKR	FAM83H	311	Q6ZRV2
STSFPLSGPPRKPQE	RUBCN	246	Q92622
KGRTPSAFPQTPAAP	EHMT1	161	Q9H9B1
LSKPNISPSHSRPPG	MED1	1186	Q15648
SAPNSPRIGSPLSPK	LARP1B	331	Q659C4
PRSAFSAGLSKPFPP	OTOL1	341	A6NHN0
TPGPNSPIFLPTDDK	ALOX15B	336	O15296
TPPQSQTPGALPAKR	F12	331	P00748
SFIPPPNTFGQAKAP	PYGO1	221	Q9Y3Y4
QLPPVTKGSQPPRFC	PIF1	346	Q9H611
LFFAPPSPPNGDKSV	RFPL1	281	O75677
TPPGEPVNSRPKAAS	SNX29	776	Q8TEQ0
GFNSPSSTPVRPPIV	SLAIN2	211	Q9P270
SPGKFRSPAAPSPLA	SLAIN2	456	Q9P270
TPPFNPNVTGPADLK	SGK2	306	Q9HBY8
AFQQGKIPPTPFSAP	SNRPC	56	P09234
NKPPAVSPGVVSPTF	TAB2	471	Q9NYJ8
RFTNSAGPPPPGFKS	SARAF	216	Q96BY9
PVSPLKFSPFEGFRP	RPS6KB2	421	Q9UBS0
KFSPFEGFRPSPSLP	RPS6KB2	426	Q9UBS0
FLPSRGPAPGSKPVQ	SLC38A5	26	Q8WUX1
ERAPPAKNTSPGPVS	PRR36	101	Q9H6K5
FSAKPSRQVPQVFPP	PROX1	371	Q92786
RGPPRKFSQPEPSAV	PRAM1	351	Q96QH2
AVTRSKDAPPFGPPI	SIPA1L3	766	O60292
GRITATPKESPNPPN	MRPS18A	51	Q9NVS2
GAAPPTPSKPLTSFL	NKX3-1	16	Q99801
LSLPFVPGRVPPSSF	OPRPN	61	Q99935
SSFSKGQPLPPLQVP	SEC31B	351	Q9NQW1
SAVLGQQSPPFPFPR	SEC31B	786	Q9NQW1
PSPQGTKAPRFVPLT	PRR12	916	Q9ULL5
RRQFPPSPSAPKIPS	PEX14	226	O75381
EKTPNSTLPPAGRPS	PAG1	366	Q9NWQ8
FLQPPTSSKPRGPVL	RHPN1	381	Q8TCX5
FPPSRSSGLPNIPVQ	TFRC	321	P02786
TKAGRGASQPPTPTP	OSM	166	P13725
PALPPQRFTGPSQTD	SOX30	506	O94993
PAEKKPPSGSQAPRT	SLX4	106	Q8IY92
PNPVKFPNRLPSAGA	ST18	536	O60284
GSPLKRPFPAAAPAV	SUPT20HL2	486	P0C7V6
KVSQPAAPPEGPRST	AFF1	521	P51825
STPVPIASKPFPTSG	CIC	681	Q96RK0
PSTIRPASPVAGSPK	COASY	171	Q13057
LRPQSAQSSFPPSPG	AUP1	276	Q9Y679
SASKFPSSGPVTPQP	AUP1	356	Q9Y679
VAGSPRIPPSQFSPA	NCOA2	496	Q15596
QGAPQRPLSTFSPAP	TCF19	156	Q9Y242
PPATNTPAPILSGKR	PRR22	371	Q8IZ63
QPPKAAAFPPGFSIS	RPF1	41	Q9H9Y2
RPSAHSPGKKTPAPQ	TNRC18	2711	O15417
PPPVAAKPTFGRSIL	TJP2	1036	Q9UDY2
NGSVSPPPFKQSPRI	TULP2	146	O00295
PTGPQRQVFSVAPPF	TTBK1	656	Q5TCY1
VTASQPPSKGPQAPA	SPEN	2861	Q96T58
TAPKQPLFVPTTSGP	SPEN	3451	Q96T58
GEPPLFSRPSTPKTS	SPEG	531	Q15772
RFPKPPNITFPQGTL	ERVFRD-1	171	P60508
FRKLPQPPQPSAATT	TIGD1	551	Q96MW7
TLPAKPSPSPGRAQE	PRR19	101	A6NJB7
PPVRIPPFSVTTANG	SLC26A11	281	Q86WA9
PTPRQKPFQSGSTPL	WDHD1	426	O75717
HRPPPIKLPSSSGNS	SUPT20H	461	Q8NEM7
KRPAVTQPGPPAATH	FAM90A2P	261	Q658T7
VSPVFSPPEPAGIKN	NEURL1B	486	A8MQ27
TSGHPAELSPRPKQP	HIVEP3	291	Q5T1R4
SLEGPTGFQPRTPKP	HIVEP3	766	Q5T1R4
KGATPLPQGRSPFAP	PRRT4	536	C9JH25
KSNTPTPRNDAPTPG	TLE3	316	Q04726
IPKNPPSGFVRASPR	ROCK1	1316	Q13464
TPPVTIPGSAKFTPN	ZNF704	311	Q6ZNC4
PCQKSPNGVRVFPPA	TRIM9	91	Q9C026
SPSLQPSFNPGKTPA	YY1AP1	466	Q9H869
FPALVSSVPKPGTAP	ZNF598	486	Q86UK7
PAPTPAPFKVGALST	VWA5B2	726	Q8N398
PSAKRSLGFLPQPVP	USP37	296	Q86T82
PGIFKQRPPISIAPS	USP24	2361	Q9UPU5
SASPPPVAGVPFFKQ	ZNF687	251	Q8N1G0
SPGHQSPLASPKVPV	ZNF687	266	Q8N1G0
GTFKTTPPAETAPLP	ZNF142	781	P52746
LFLSPPAPAPKNGSS	WNK1	16	Q9H4A3
RLGKSSPAQPASPHP	XKR5	571	Q6UX68
SRKETPQFFPSSPPP	SEMA6D	801	Q8NFY4
GTTTKPLAPNPSFSP	TNFRSF1A	261	P19438
TQFPPVASSGLPSIP	TFR2	341	Q9UP52
PSFGQSPSPTFIPRS	TOB2	156	Q14106
PPSQRGSAPQSGAKP	ZNF219	566	Q9P2Y4
EPFPPSSPLQKGGSF	TRIO	2471	O75962
AKPPPLPRSNTVASF	TSC2	1261	P49815
VSRASAAKPPSFPPL	ZFHX3	3621	Q15911
SAAPPPQSREPGKVF	ZNF628	236	Q5EBL2
AVPGRHPLPSPKNTS	WNK3	896	Q9BYP7
FTFPQAVGEPSLKPP	KMT2D	2536	O14686
PPFSDKPSIPAGRSL	LCP2	261	Q13094
KTAGPNTPPDFPISL	NACA	291	E9PAV3
PSFPSPKPGSERLSF	NECTIN2	91	Q92692